iconOpen Access

ARTICLE

crossmark

Demographic Heterogeneities in a Stochastic Chikungunya Virus Model with Poisson Random Measures and Near-Optimal Control under Markovian Regime Switching

Maysaa Al-Qurashi1, Ayesha Siddiqa2, Shazia Karim3, Yu-Ming Chu4,5,*, Saima Rashid2,*

1 Department of Mathematics, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
2 Department of Mathematics, Government College University, Faisalabad, 38000, Pakistan
3 Department of Basic Sciences and Humanities, University of Engineering and Technology Lahore, Faisalabad Campus, Faisalabad, 38000, Pakistan
4 Institute for Advanced Study, Honoring Chen Jian Gong Hangzhou Normal University, Hangzhou, 311121, China
5 Department of Mathematics, Huzhou University, Huzhou, 313000, China

* Corresponding Authors: Yu-Ming Chu. Email: email; Saima Rashid. Email: email

(This article belongs to the Special Issue: Recent Developments on Computational Biology-II)

Computer Modeling in Engineering & Sciences 2025, 145(2), 2057-2129. https://doi.org/10.32604/cmes.2025.071629

Abstract

Chikungunya is a mosquito-borne viral infection caused by the chikungunya virus (CHIKV). It is characterized by acute onset of high fever, severe polyarthralgia, myalgia, headache, and maculopapular rash. The virus is rapidly spreading and may establish in new regions where competent mosquito vectors are present. This research analyzes the regulatory dynamics of a stochastic differential equation (SDE) model describing the transmission of the CHIKV, incorporating seasonal variations, immunization efforts, and environmental fluctuations modeled through Poisson random measure noise under demographic heterogeneity. The model guarantees the existence of a global positive solution and demonstrates periodic dynamics driven by environmental factors. A key contribution of this study is the formulation of a stochastic threshold parameter, , which characterizes the conditions for disease persistence or extinction under random environmental influences. Although our analysis highlights age-specific heterogeneities to illustrate differential transmission risks, the framework is general and can incorporate other vulnerable demographic groups, ensuring broader applicability of the results. Using the Monte Carlo Markov Chain (MCMC) method, we estimate = 1.4978 (95% CI: 1.4968–1.5823) based on CHIKV data from Florida, USA, spanning 2005 to 2017, suggesting that the outbreak remains active and requires targeted control strategies. The effectiveness of immunization, screening, and treatment strategies varies depending on the prioritized demographic groups, due to substantial differences in CHIKV incidence across age categories in the USA. Numerical simulations were conducted using the truncated Euler–Maruyama method to robustly capture the stochastic dynamics of CHIKV transmission with Poisson-driven jumps. Employing an iterative approach and assuming mild convexity conditions, we formulated and solved a parameterized near-optimality problem using the Ekeland variational principle. Our findings indicate that vaccination campaigns are significantly more effective when focused on vulnerable adults over the age of 66, as well as individuals aged 21 to 25. Furthermore, enhancements in vaccine efficacy, diagnostic screening, and treatment protocols all contribute substantially to minimizing infection rates compared to current standard approaches. These insights support the development of targeted, age-specific public health interventions that can significantly improve the management and control of future CHIKV outbreaks.

Keywords

Chikungunya virus; mathematical modeling; age-structure; poisson random measure; monto-carlo markov chain; extinction; persistence in mean; stochastic near-optimal control; Ekeland’s variational principle

1  Introduction

The Aedes mosquito-borne alphavirus (family Togaviridae), known as the CHIKV, has recently resurfaced in several regions worldwide, leading to widespread epidemics. Chikungunya fever is primarily characterized by symptoms such as fever, arthralgia, and, in some cases, a maculopapular rash. Bioactive compounds found in hops (Humulus lupulus, Cannabaceae), particularly acylphloroglucinols—commonly referred to as α- and β-acids—have demonstrated significant antiviral activity against CHIKV without exhibiting cytotoxic effects. Vector-borne diseases are infections transmitted to humans via vectors harboring microbial organisms, viruses, or bacteria. CHIKV, an arthropod-borne alphavirus, is propagated predominantly by Aedes aegypti and Aedes albopictus mosquitoes—the same vectors responsible for Zika, dengue, and yellow fever transmission [1]. CHIKV is a positive-sense, single-stranded RNA virus (11.8 kb) that encodes four nonstructural proteins (nsP1, nsP2 [helicase], nsP3, nsP4 [RNA-dependent RNA polymerase]) and six structural proteins (C, E3, E2, E1, 6K, and TF) [2]. Characterized clinically by arthralgia, myalgia, and tachycardia, CHIKV has expanded from its African origins to South America, particularly Brazil. Between 2013 and 2019, the Pan American Health Organization (PAHO) recorded over 600 CHIKV-related deaths in Latin America, likely underestimating the true global mortality burden.

Recent outbreaks of CHIKV have been markedly distinct from previous ones, characterized by accelerated transmission and broader geographic spread, often originating in migrant communities from regions where the virus remains endemic. A nationwide epidemic in Malaysia in 1998, primarily driven by workforce migration, exemplifies this trend [3]. Following a 20-year hiatus, Indonesia experienced a significant resurgence from 2001 to 2003 [4]. The 2005 global outbreak in India, affecting 1.4 million individuals, represents one of the most severe in recent history, occurring 32 years after the region’s last major CHIKV event [5]. The national economic impact of this epidemic was estimated at 45.26 disability-adjusted life years per million, approximately equating to 26,000 cases. In 2006, Réunion Island, located southwest of Madagascar in the Indian Ocean, witnessed an epidemic that impacted one-third of its population [6]. This outbreak was particularly severe, with a notably high fatality rate and significant neurological, hepatocellular, and cardiovascular complications. CHIKV, while similar to Zika and dengue, shows distinct clinical features. In endemic areas, 10%–70% are infected and 50%–97% develop symptoms after 4–7 days [7]. Neonates are highly vulnerable, and individuals over 65 have a five-fold higher fatality rate. The disease has an acute phase (7 days) and a persistent/recurrent phase lasting months or years, with acute polyarthralgia affecting 30%–90% of cases; some patients may also experience coronary, neurological, or ocular complications [8]. Chronic CHIKV infection poses ongoing health challenges. During the Réunion Island epidemic, 43%–75% had symptoms one year post-infection, including arthritic pain, fatigue, and neuralgia. Up to 50% may experience persistent pain, often linked to osteoarthritis and ankylosing spondylitis, affecting joints and cartilage [9].

CHIKV transmission occurs in two distinct phases: the forest and city transmission cycles. In the urban cycle, propagation follows a mosquito-mediated human-to-human transmission, while the forest cycle involves a mosquito-borne transmission from animals to humans route [10]. The forest phase is the initial mechanism for the virus’s persistence in Africa [11], whereas the urban cycle dominates in densely populated areas, where Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus, act as the primary vectors, and humans are the principal hosts [9]. Although Ae. aegypti has traditionally been the dominant vector, the significance of Ae. albopictus has increased, particularly in recent outbreaks in Europe, Gabon, and Réunion [12]. However, as evidenced by the 2013 Caribbean epidemic, Ae. aegypti remains a major vector despite this shift [13]. The spread of Ae. albopictus as a prominent vector has been linked to a genetic variation in the virus’s E1 protein (A226V polymorphism), which enhances the virus’s transmissibility to this mosquito species [9]. Additionally, vertical transmission of CHIKV, particularly in cases following the 2005 epidemic, has been observed, though its validity remains debated [14]. This mode of transmission is considered particularly concerning when the mother remains infected in the days following childbirth [9,11,13].

In humans, the transmission process of CHIKV is well understood, with certain cell types exhibiting heightened susceptibility. Human endothelial and epidermal cells, primordial fibroblasts, and monocyte-derived lymphocytes are particularly prone to infection, facilitating viral propagation. Conversely, CHIKV replication is generally not supported by major lymphocytes, monocytes, lymphoma cells, monocytoid cells, or dendritic cells derived from monocytes [9]. However, this finding remains contentious, as CHIKV-confirmed fibroblasts have been observed in vivo in virus-contaminated individuals [11]. Following initial infection, the host mounts an immune activation, however the infection subsequently spreads to lymphocytes and circulates through various organs [13]. This parasitic phase, marked by widespread viral dissemination, is when mosquitoes can acquire the virus from infected hosts during feeding, facilitating further transmission.

Several aspects of the immune response to CHIKV remain unresolved. To eliminate the virus, CHIKV activates non-hematopoietic mitochondria, primarily fibroblasts, triggering a type I interferon response at the site of infection [15]. The interferon response is regulated by factors 3 and 7, which are less effective in older individuals but are crucial for defending against infection in neonates who lack these factors [15]. Brito and Teixeira [16] highlighted that CHIKV-related fatalities were often underreported within healthcare systems, largely due to limited awareness of the virus’s clinical manifestations and complications. This underrecognition is understandable, given that CHIKV had only recently emerged in the Americas. The authors noted that secondary causes of death—such as cardiac, respiratory, or metabolic conditions—were frequently documented without acknowledging CHIKV infection as the primary or contributing factor. In individuals with persistent symptoms, CD4+ T-cells are more prevalent in synovial tissues, while CD8+ T-cells are found in the skin during the critical phase of the illness [16]. In addition, bone marrow mesenchymal antigen-2 may help mitigate autoimmune responses triggered by CHIKV and protect lymphoid tissue from damage [17].

To better understand biophysical phenomena and the unpredictable nature of transmission of infections, mathematical models have been extensively used [18,19]. Additionally, they are essential instruments for assessing and choosing the best means of control [20]. Sir Ronald Ross’s groundbreaking research on plasmodium established the groundwork for viral infection modeling. Plenty of models have been created since then. Deterministic ordinary differential equations (ODEs) were commonly employed for initial simulations, which assumed consistent death rates and ignored the effects of demographic characteristics and density of the population on morbidity. In [21], Bellan showed that the consequences of vector prevention techniques might be greatly overestimated if age-independent morbidity is assumed. The propagation of many ailments, such as dengue fever, human liver, tumor cells in immunogenetic tumour, HIV with CD4+ t-cells, SARS (severe acute respiratory syndrome), Zika virus, and, most recently, Nipah virus, is also known to be significantly impacted by density of population [18,20]. Recently, Olayiwola and Oluwafemi [22] modeled Tuberculosis dynamics with awareness and vaccination using the Laplace-Adomian method. Olayiwola et al. [23] studied the impact of booster vaccines on managing a new COVID-19 variant using the Laplace-Adomian decomposition method. Mohamed Ali et al. [24] examined stability criteria and optimal control measures for a fractional-order model of human papillomavirus (HPV) infection and cervical cancer. El-Mesady et al. [25] investigated optimal control strategies to reduce HPV transmission in a fractional-order mathematical model.

Meanwhile, the effects of population density have been incorporated into various simulations of insect-borne disease transmission [20]. In [21], the authors considered density-dependent larval mortality rates, but did not account for density effects on transitions between aquatic developmental stages. Although density-dependent mortality during the aquatic phase was included in the basic model of Aedes aegypti population dynamics proposed in [9], the three distinct aquatic stages were merged into a single class. This simplification poses challenges when assessing the impact of specific vector control strategies, as pharmaceutical treatments may affect eggs and larvae differently [14].

Similarly, although Buonomo [26] incorporated mortality driven by population density in humans and mosquitoes within a malaria transmission model, the model did not differentiate between the various aquatic stages of mosquito development via critical aspect for designing effective mosquito control measures. In the same vein, Chitnis et al. [27] studied the propagation processes of the CHIKV by considering only the egg and larval stages of the mosquito population, modeling the effects of density solely on recruitment rates and developmental progression. However, they did not address the impact of larval density on mortality rates, instead focusing exclusively on density-dependent stage advancement during the aquatic maturation process.

Achieving probabilistic optimal control becomes particularly challenging when strict constraints are present. In simpler cases, it may even be impossible to realize true optimal control due to the inherent unpredictability of the system, as highlighted in certain studies [28]. Nevertheless, even in such complex environments, it is often possible to attain near-optimal solutions for stochastic processes [29]. In many applications—such as economics, technology, and beyond developing near-optimal control strategies within an appropriate framework is crucial for achieving desired outcomes. The growing demand for probabilistic near-optimal control has driven significant advancements in this field, establishing it as a key component of dynamic regulation [28,29].

To address these challenges, researchers have developed controlled frameworks based on continuous-time models and finite-state Markov chains, particularly for systems where stochastic differential equations (SDEs) experience abrupt changes phenomena frequently encountered in fields like financial markets, risk management, and asset allocation [30]. Moreover, necessary conditions for ensuring near-optimal control in such complex systems have been rigorously established [30]. It is also widely recognized that environmental perturbation contributes a crucial role in the spread of viral diseases in real-world settings [31]. Since SDEs can more accurately capture the randomness inherent in infection patterns, simulating epidemic outbreaks within a stochastic framework is considered a more reliable approach. Consequently, numerous studies have explored how external noise influences epidemic dynamics [32]. Dereich et al. [33] investigated the behavior of a multilevel Monte Carlo algorithm within an epidemiological framework where population growth remains stable, independent of disease incidence. Their findings demonstrated that the system sustains at least one robust and favorable recurring pattern, ensuring the persistence of the epidemic in a stable environment.

Beyond white noise, Poisson noise is a critical factor in epidemiological simulations, inducing transitions between distinct environmental states [33,34]. In this work, we account for the influence of Poisson noise [35], which drives regime shifts corresponding to varying environmental conditions. For example, fish population growth rates can differ substantially between dry and wet seasons. These transitions, typically following an exponential waiting time distribution, are characterized by a memoryless property [36].

Inspired by the aforementioned literature, we propose a novel model for CHIKV transmission that incorporates density-dependent mortality rates within the human population. This model is calibrated using demographic data from a major CHIKV outbreak in Florida, USA, through the MCMC method. To more effectively quantify the influence of key parameters, a global sensitivity analysis is conducted, focusing on the primary thresholds that govern the model’s dynamics. Incorporating a Poisson random measure, we extend the model to a stochastic framework that accounts for dual infection dynamics, environmental noise with random jumps, and a saturated transmission rate. This stochastic model establishes sufficient conditions for both the persistence and potential eradication of the virus, offering a robust foundation for analyzing long-term disease behavior under fluctuating environmental conditions. Additionally, we address the near-optimal control problem in random frameworks influenced by Poisson noise and regime-switching, without the restrictive requirement of second-order continuous differentiability in the drift and diffusion coefficients. Necessary and sufficient requirements for achieving near-optimal control strategies—such as targeted vaccination and optimized intervention timing—are derived, demonstrating that any ϵ-optimal insight minimizes the Hamiltonian function involving error of order ϵ3/16. Furthermore, the model establishes that an ϵ-minimum condition guarantees near-optimality with an error order of ϵ1/2. This comprehensive framework significantly enhances the ability to design efficient and effective public health interventions against vector-borne diseases such as Chikungunya.

The organization of the work is as follows: Section 2 introduces our autonomous model, which incorporates the adaptive immune response and latently infected cells, and is then extended to a stochastic CHIKV model involving Gaussian white noise and Poisson random measure. Section 3 focuses on the mathematical analysis of the model in relation to the Poisson random measure. Section 4 presents and analyzes the near-optimality control conditions, including numerical simulations and an efficiency analysis. Section 5 discusses model calibration, population stratification, and the contact matrix for the CHIKV model. Section 6 conducts a sensitivity analysis and further examines the optimal control model, including numerical simulations and supporting arguments. Finally, the paper concludes with a summary in the last section. By rigorously analyzing individual class behaviors and leveraging advanced methodologies like Possion random measure, the entire procedurehas been illustrated in the flowchart presented in Fig. 1.

images

Figure 1: Flow diagram of the overall methodology

2  Model Description

In what follows, the development of CHIKV is dependent on the transmission properties of the virus. Chikungunya fever, which is caused by the CHIKV, an alphavirus spread by mosquitoes, is distinguished by an acute fever that appears suddenly, along with eruption, extreme arthritis in the joints, and exhaustion. The Asian continent, the European Union, and the Americas have all seen occurrences of such illness, which is mostly propagated by Aedes aegypti and Aedes albopictus mosquitoes [1,3,4]. Research indicates a clear pattern in the spread of CHIKV [14]. To better understand this phenomenon, we propose two models as follows: Firstly, the interaction between the infectious agent, host cells, and immune components such as T cells and antibodies—is modeled within an adaptive immune response framework for CHIKV. This framework helps explain immune variability during infection and fluctuations in transmission. We proceed by presenting the adaptive immune response model, represented by the following system of ODEs:

{dS(t)dt=πϖ1S(t)βS(t)V(t),dI(t)dt=βS(t)V(t)ϖ2I(t)ϵI(t)Z(t),dV(t)dt=ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t),dB(t)dt=ϖ6+ϖ7B(t)IV(t)δB(t),dZ(t)dt=ϖ8+ϖ9I(t)Z(t)ϖ10Z(t),(1)

subject to the ICs: S(0)=S0,I(0)=I0,V(0)=V0,B(0)=B0 and Z(0)=Z0. However, system (1) operates on the following assertions:

(i)   The number of sensitive cells, S(t), decreases due to natural loss and interaction with virus particles V(t), and fresh vulnerable cells are injected at a steady rate (see Shu et al. [37]).

(ii)   Infected cells, I(t), are formed through virus-cell interaction and can be removed naturally or destroyed by cytotoxic T-lymphocytes, Z(t) (see Dubey et al. [38]).

(iii)   Infected cells emit V(t), which are neutralized through interactions with antibodies. B(t) cells are activated by infection and eventually die. The population of cytotoxic T cells, Z(t), grows and then decreases at a steady rate (see Handel and Antia [39]).

Secondly, by accounting for lymphocytes that have been infected but are not yet infectious, a CHIKV model incorporating latently infected cells offers a more accurate representation of transmission dynamics. This enhancement captures the latent period between viral entry and active replication, improving the precision of predictive algorithms. The incubation phase influences viral propagation potential, timing of immune responses, and viral load buildup. Including this stage strengthens estimates for outbreak control and therapeutic intervention strategies. The following extended framework of ODEs builds upon the previous model by incorporating latently infected cells:

{dS(t)dt=πϖ1S(t)βS(t)V(t),dL(t)dt=(1ρ)βS(t)V(t)(Θ+φ)L(t),dI(t)dt=ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t),dV(t)dt=ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t),dB(t)dt=ϖ6+ϖ7V(t)B(t)δB(t),dZ(t)dt=ϖ8+ϖ9I(t)Z(t)ϖ10Z(t).(2)

subject to the ICS: S(0)=S0, L(0)=L0, V(0)=V0, B(0)=B0, Z(0)=Z0. These values determine the initial population sizes of each compartment. The dynamics of the compartmental model, capturing the transitions between the five key compartments.

The formulation of the proposed CHIKV models is grounded in established immunological and epidemiological modeling frameworks. The first model (1) focuses on the interaction between susceptible host cells, infected cells, virus particles, and immune responses (T-cells and antibodies). Such compartmental structures have been widely adopted in viral dynamics research (see Shu et al. [37]; Dubey et al. [38]; Handel and Antia [39]) as they capture the essential mechanisms of infection progression and immune regulation.

However, to provide a more realistic description of CHIKV transmission, it is crucial to account for the latent phase of infection, where cells are infected but not yet producing new virions. This motivates the extension presented in (2), where a new compartment for latently infected cells is introduced. Similar extensions have been successfully employed in the study of other mosquito-borne viral infections (see e.g., Buonomo [26], Chitnis et al. [27], Shu et al. [37]; Dubey et al. [38]). Incorporating latency reflects the biological reality that the virus requires an incubation period before active replication, thereby improving predictive accuracy for outbreak size, timing, and intervention strategies.

Thus, the transition from the baseline model (1) to the extended model (2) is justified both biologically and mathematically, ensuring that the formulation aligns with state-of-the-art approaches in infectious disease modeling. This refinement allows the model to better capture observed CHIKV transmission dynamics and provides a more solid foundation for evaluating control measures.

This second model (2) modifies the initial system (1) by incorporating the latently infected cells class L(t). All the parameters are described in Table 1.

images

The basic reproductive number

R0=βδπϖ3ϖ10ϖ1(ϖ5ϖ6+δ)(ϵϖ8+ϖ2ϖ10),

serves as a threshold: if R0>1, infection can spread, while R0<1 indicates eventual eradication. Public health relevance lies in its components: reducing β (vector control), lowering ϖ3 (antivirals), or enhancing immune clearance terms in the denominator (vaccination, improved diagnostics) all decrease R0. Thus, R0 guides which interventions most effectively reduce transmission, although under regime switching and stochastic effects the refined threshold R0L provides a more realistic measure. Effective control requires a combined strategy, where vector reduction lowers transmission opportunities while immune-strengthening interventions (e.g., vaccination or therapeutics) enhance host resistance, together providing the most impactful reduction in spread.

For the latently infected cells, we have ¯=S(t)+L(t)+I(t)+V(t)+B(t)+Z(t). Now we convert the classical latently infected model to a Gaussian white noise version as follows:

{dS(t)=[πϖ1S(t)βS(t)V(t)]dt+σ1S(t)dB1(t),dL(t)=[(1ρ)βS(t)V(t)(Θ+φ)L(t)]dt+σ2L(t)dB2(t),dI(t)=[ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t)]dt+σ3I(t)dB3(t),dV(t)=[ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t)]dt+σ4V(t)dB4(t),dB(t)=[ϖ6+ϖ7V(t)B(t)δB(t)]dt+σ5B(t)dB5(t),dZ(t)=[ϖ8+ϖ9I(t)Z(t)ϖ10Z(t)]dt+σ6Z(t)dB6(t).(3)

In spite of the inherent advantages associated with Poisson random measure perturbations, their utility may be further amplified if noise-modulated drift velocity remains inside an optimal threshold domain. The integration of both local and nonlocal Lipschitz criteria underscores that embedding Poisson random measure disturbances can significantly enhance the fidelity and variability of transmitted information, particularly in feedback-driven epidemic models governed by arbitrary SDEs. As highlighted in previous studies [40], Poisson random measure noise exhibits notable advantages over conventional Gaussian disturbances in the context of theoretical epidemiological modeling. Nevertheless, its implementation introduces elevated computational complexity, which poses additional analytical challenges. The jump-diffusion framework incorporating Poisson random measures extends classical formulations by providing a more precise depiction of phenomena such as the abrupt firing of neuronal membrane potentials. Furthermore, the incorporation of such noise mechanisms has been shown to improve the robustness and temporal precision of recurrent neural network (RNN) architectures. When applied to the system described in Eq. (3), the use of Poisson random measure noise leads to a system of compound Poisson-driven SDEs, as detailed in [41].

{dS(t)=[πϖ1S(t)βS(t)V(t)+σ1S(t)dB1(t)]dt+ΦΘ1(Ψ)S(t)¯(dt,dΨ),dL(t)=[(1ρ)βS(t)V(t)(θ+φ)L(t)]dt+σ2L(t)dB2(t)+ΦΘ2(Ψ)L(t)¯(dt,dΨ),dI(t)=[ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t)]dt+σ3I(t)dB3(t)+ΦΘ3(Ψ)I(t)¯(dt,dΨ),dV(t)=[ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t)]dt+σ4V(t)dB4(t)+ΦΘ4(Ψ)V(t)¯(dt,dΨ),dB(t)=[ϖ6+ϖ7V(t)B(t)δB(t)]dt+σ5B(t)dB5(t)+ΦΘ5(Ψ)B(t)¯(dt,dΨ),dZ(t)=[ϖ8+ϖ9I(t)Z(t)ϖ10Z(t)]dt+σ6Z(t)dB6(t)+ΦΘ6(Ψ)Z(t)¯(dt,dΨ),(4)

whereas

Ω1=σ1S(t)dB1(t)+ΦΘ1(Ψ)S(t)¯(dt,dΨ),Ω2=σ2L(t)dB2(t)+ΦΘ2(Ψ)L(t)¯(dt,dΨ),Ω3=σ3I(t)dB3(t)+ΦΘ3(Ψ)I(t)¯(dt,dΨ),Ω4=σ4V(t)dB4(t)+ΦΘ4(Ψ)V(t)¯(dt,dΨ),Ω5=σ5B(t)dB5(t)+ΦΘ5(Ψ)B(t)¯(dt,dΨ),Ω6=σ6Z(t)dB6(t)+ΦΘ6(Ψ)Z(t)¯(dt,dΨ).

A new scheme of the associated SDE model is built to clarify the dynamical interconnections across the CHIKV propagation system, specifically in the occurrence of latently infectious cell compartments. The chronological progression of every demographic compartment with deterministic and stochastic consequences involving Gaussian white noise and Poisson random measure disruptions. Nonlinear prevalence factors control compartment transitions, and stochastic stimuli are included to account for unpredictable interaction occurrences and modifications in the environment. In particular, the abrupt activation of persistent lymphocytes is represented by a Poisson jump mechanism and a delay differential term, which effectively characterize the pattern of latent infections. Transitions such as infection, latency stimulation, virus generation, immune system stimuli, and natural eradication are indicated in the aforementioned system.

However, the compensated Poisson random measure indicated by ¯, it can be described as

¯(dt,dT)=(dt,dT)α(dt)dΨ.

The expression Θ(t) represents the left limit. The terms Bȷ(t)ȷ{1,,6} represent autonomous classical Brownian motions, started at Bȷ(0)=0. The parameters ξȷ, where ȷ{1,,6}, indicate the intensity of the stochastic perturbations, which incorporate Gaussian white noise effects into the epidemiological model. All additional components retain the identical interpretation. The Poisson random measure in this case is ¯, and the strength of its estimate becomes α(.). Also, the mapping α stated on measure set Ψ[0,) possessing the features α(Ψ)< and Θω0, (ω={1,,6}).

2.1 Basic Concept

This section presents the foundational definitions and lemmas pertinent to stochastic analysis. The notation and structural conventions adopted here align with those outlined in [42], and will be consistently employed throughout this study.

Q(t)=1t0tQ(ȷ)dȷ.(5)

Lemma 1: ([43]) To facilitate our investigation, we shall employ two essential presumptions, denoted (A1(t)) and (A2(t)). Such requirements are necessary for establishing existence-uniqueness for global non-negative outcome for framework (3).

(A1(t)): for all M>0 LM>0 such that

Φ|ΛI(Ψ1,)ΛI(Ψ2,)|2dα(Ψ)LM|12|2,ȷ={1,2,,6},(6)

with |1||2|S, where

Λ1(,Ψ)=Θ1(Ψ) for =S(t),Λ2(,Ψ)=Θ2(Ψ) for =L(t),Λ3(,Ψ)=Θ3(Ψ) for =I(t),Λ4(,Ψ)=Θ4(Ψ) for =V(t),Λ5(,Ψ)=Θ5(Ψ) for =B(t),Λ6(,Ψ)=Θ6(Ψ) for =Z(t),(7)

where t represents the compensated stochastic parameter.

(A2(t)):|log(1+Θȷ())| for Θȷ()>1,ȷ={1,2,,6}, where is a fixed non-negative number.

Theorem 1: For a stochastic model (4) (S(t),L(t),I(t),V(t),B(t),Z(t)) is a solution containing ICs (S(0),L(0),I(0),V(0),B(0),Z(0))R6+, then

limtS(t)+L(t)+I(t)+V(t)+B(t)+Z(t)t=0.(8)

Furthermore, if max{ϖ10ιh,ϖ10ȷh{>σ12+σ22+σ32+σ42+σ52+σ62t, then

limt0tS(s)dB1(s)t=0,limt0tL(s)dB2(s)t=0,limt0tI(s)dB3(s)t=0,limt0tB(s)dB4(s)t=0,limt0tV(s)dB5(s)t=0,limt0tZ(s)dB6(s)t=0.(9)

Thus, the solutions of CHIKV model (4) possess the subsequent features;

limtsupS(t)=πϖ1,limtsupL(t)=0,limtsupI(t)=0,limtsupB(t)=ϖ6δ,limtsupV(t)=0,limtsupZ(t)=ϖ8ϖ10.(10)

Proof: The supporting arguments for this lemma are analogous to those provided for Lemmas 2.1 and 2.2 in [44]; therefore, they are omitted here for brevity in the context of this analysis.

The previously outlined definitions of mean persistence are particularly noteworthy, as highlighted in [42].

Definition 1: ([45])To establish the property of extinction or persistence, the stochastic model (4) is required to satisfy the following conditions:

limtinf1t0tW(s)ds>0, a.s.(11)

The criteria outlined herein are consistent with those detailed in [42], wherein the associated lemmas delineate the requisite conditions for the persistence of infection.

Lemma 2: (Strong law) ([45]) Considering a real-continuous mapping S={S}0t, the local martingale criterion occurs if it disappears as t0 and

limtS,St=, a.s.limtΦtS,St=0, a.s.limtsupS,Stt<0, a.s.limtStt=0 a.s.(12)

Lemma 3: ([45]) Consider h([0,)×B¯(0,)) and G([0,)×B¯R)limtG(t)t=0, a.s. if t0, then

logf2(t)Γ0(t)Γ0th(S)dS+G(t), a.s.

Therefore, we have

limtinfg(t)Γ0Γ, a.s.

Here, Γ and Γ0 indicate positive constants, respectively.

Definition 2: (Approximate optimal control) ([46]) A set of permissible control strategies {(ϝηδ,Vηδ)} indexed by δ>0 and any member (ϝηδ,Vηδ), or just Vηδ, within this set is termed as an approximate optimal control if the following condition holds:

|J(0,ϝ0,Vηδ)J(0,ϝ0)|ϵ(δ),(13)

where

J(0,ϝ0)=infVηVad[0,T]J(0,ϝ0,Vη).(14)

The function ϵ(δ) satisfies:

ϵ(δ)0asδ0.(15)

If a fixed 𝒞>0 such that:

ϵ(δ)=𝒞δp,(16)

then Vηδ is termed as approximate optimal control of order δp.

Definition 3: (Generalized gradient in Clarke’s sense) [47] Consider Φ():ΦR as a locally Lipschitz function on a convex domain ΦRn. The generalized gradient for Clarke Ψ at ϝ^Φ is stated as:

ϝΨ(ϝ^)={ξRnξqφ0(ϝ^;q),qRn},(17)

where

Ψ0(ϝ^;q)=lim supϝϝ^p0+Φ(ϝ+pq)Φ(ϝ)p,ϝ𝒟,ϝ+pqΦ.(18)

Lemma 4: ([47]) Suppose that a1,a2,,an are real-valued functions. Then the sunsequent inequality holds:

|a1+a2++an|mCm(|a1|m+|a2|m++|an|m),(19)

where m>0 and

Cm={1,0<m1,nm1,m>1.(20)

Lemma 5: ([47]) Suppose that there is a complete metric space (A,d) and a bounded operator ():AR which is also lower-semicontinuous. If q>0 and Vq()ϝ such that:

(Vq())infV()ϝ(V())+q.(21)

2.2 Global Positive Solution

To enhance the realism of the CHIKV transmission model, we incorporate a compartment for latently infected cells and introduce stochasticity via a Poisson random measure. The resulting stochastic model (4) serves as a physiological analogue for the population dynamics of CHIKV infection. This model formulation requires the presence of a global, bounded, and non-negative solution. To analyze the well-posedness of the system defined by (4), we adopt the standard assumptions (A1) and (A2) stated in Lemma 1. These hypotheses enable us to establish the existence-uniqueness of a global solution. The forthcoming analysis will rigorously demonstrate that, under these assumptions, the stochastic CHIKV model with latently infected cells driven by a Poisson random measure permits a unique global positive solution.

Theorem 2: Surmise that the stochastic model (4), defined for t0, permits a unique solution (S(t),L(t),I(t),V(t),B(t),Z(t)) corresponding to ICs (S(0),L(0),I(0),V(0),B(0),Z(0))R+6. Furthermore, the solution stays in R+6 having probability one, means that (S(t),L(t),I(t),V(t),B(t),Z(t))R+6  t0, almost surely.

Proof: Since the drift and diffusion are guaranteed to be locally Lipschitz by the requirement (A1), there will be a time t at which the suggested concern will have a locally specific solution in the range [0,πe). The explosion phase is represented here by πe; researchers are directed to [42] for more details. To establish that the outcome is global, it need to be shown that πe= is adequate. In order to illustrate this, let K0 be a large enough non-negative real number such that each outcome falls inside the range [1K0,K0]. As a result, given KK0, permit

πK={inft[0,πe):1Kmin{}orKmax{}},(22)

where =(S(t),L(t),I(t),B(t),V(t),Z(t),(t),IΛ(t)). Here, inf=. Moreover, πK increases as K. Suppose that πK possesses a limit of π, It is almost a given that ππe. Alternatively, it is necessary to demonstrate that π=. If this supposition is false, then the constant T>0 and Φ lie within (0, 1) such that

P{πT}>Φ.(23)

So that, there is a natural number K1K0, the following holds

εP{TπK},KK1.(24)

To demonstrate the remaining part of the hypothesis, we proceed by constructing the mapping as follows:

dU()=LU()dt+σ1(SQ)d1(t)+σ2(L1)d2(t)+σ3(I1)d3(t)+σ4(B1)d4(t)+σ5(V1)d5(t)+σ6(Z1)d6(t)+Φ[Θ1()S𝒬log(Θ1(Ψ)+1)]¯(dt,dΨ)+Φ[Θ2()Llog(Θ2(Ψ)+1)]¯(dt,dΨ)+Φ[Θ3()Ilog(Θ3(Ψ)+1)]¯(dt,dΨ)+Φ[Θ4()Blog(Θ4(Ψ)+1)]¯(dt,dΨ)+Φ[Θ5()Vlog(Θ5(Ψ)+1)]¯(dt,dΨ)+Φ[Θ6()Zlog(Θ6(Ψ)+1)]¯(dt,dΨ).(25)

The aforementioned relationship defines the LU operator as a mapping from R6+ to R+. To demonstrate the remaining part of the hypothesis, we proceed by explicitly constructing this mapping as follows:

LU=(1𝒬S)(πϖ1S(t)βS(t)V(t))+(11L)+((1ρ)βS(t)V(t)(Θ+φ)L(t))+(11I)(ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t))+(11B)(ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t))+(11V)(ϖ6+ϖ7V(t)B(t)δB(t))+(1𝒬Z)(ϖ8+ϖ9I(t)Z(t)ϖ10Z(t))+𝒬σ122+σ222+σ322+σ422+σ522+σ622+Φ[𝒬Θ1(Ψ)𝒬log(Θ1(Ψ)+1)]t(dΨ)+Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]t(dΨ)+Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]t(dΨ)+Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]t(dΨ)+Φ[Θ5(Ψ)log(Θ5(Ψ)+1)]t(dΨ)+Φ[Θ6(Ψ)log(Θ6(Ψ)+1)]t(dΨ)π+ϖ1Q+Θ+φ+ϖ2+ϖ6ϖ7+ϖ4+ϖ10+𝒬σ122+σ222+σ322+σ422+σ522+σ622+Φ[𝒬Θ1(Ψ)𝒬log(Θ1(Ψ)+1)]t(dΨ)+Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]t(dΨ)+Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]t(dΨ)+Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]t(dΨ)+Φ[Θ5(Ψ)log(Θ5(Ψ)+1)]t(dΨ)+Φ[Θ6(Ψ)log(Θ6(Ψ)+1)]t(dΨ)π+ϖ1Q+Θ+φ+ϖ2+ϖ6ϖ7+ϖ4+ϖ10+𝒬σ122+σ222+σ322+σ422+σ522+σ622+Φ[𝒬Θ1(Ψ)𝒬log(Θ1(Ψ)+1)]t(dΨ)+Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]t(dΨ)+Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]t(dΨ)+Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]t(dΨ)+Φ[Θ5(Ψ)log(Θ5(Ψ)+1)]t(dΨ)+Φ[Θ6(Ψ)log(Θ6(Ψ)+1)]t(dΨ).

Furthermore, (22) ensures the inequality S+L+I+B+Z+V1, thus

LUπ+ϖ1Q+Θ+φ+ϖ2+ϖ6ϖ7+ϖ4+ϖ10+𝒬σ12+σ22+σ32+σ42+σ52+σ622+Φ[𝒬Θ1(Ψ)S𝒬log(Θ1(Ψ)+1)]t(dΨ)+Φ[Θ2(Ψ)Llog(Θ2(Ψ)+1)]t(dΨ)+Φ[Θ3(Ψ)Ilog(Θ3(Ψ)+1)]t(dΨ)Φ[Θ4(Ψ)Blog(Θ4(Ψ)+1)]t(dΨ)+Φ[Θ5(Ψ)Vlog(Θ5(Ψ)+1)]t(dΨ)Φ[𝒬Θ6(Ψ)Z𝒬log(Θ6(Ψ)+1)]t(dΨ)=O.

For a non-negative O and an automatons fixed (S,L,I,B,V,Z), we arrive at the following:

𝒰()dt+σ1(S1)dB1(t)+σ2(L1)dB2(t)+σ3(I1)dB3(t)+σ4(V1)dB4(t)+σ5(B1)dB5(t)+σ6(Z1)dB6(t).(26)

By evaluating the integral of both sides of Eq. (26) over the interval from 0 to TπK, the following can be articulated as

E𝒰(S(TπK),L(TπK),I(TπK),B(TπK),V(TπK),Z(TπK))𝒰(S(0),L(0),I(0),V(0),B(0),Z(0))+KT<.(27)

Fix ΩK={πKt} for KK1 by (24), P(ΩK)ε. Observing each ϖ9ΩK, at least one of S(πK,ϖ9),L(πK,ϖ9),I(πK,ϖ9),V(πK,ϖ9),H(πK,ϖ9), also R(πK,ϖ9), which is equal either {k or 1k}. Consequently, S(πK,ϖ9),L(πK,ϖ9),I(πK,ϖ9),V(πK,ϖ9),H(πK,ϖ9) and R(πK,ϖ9) in no way is less than {K1logK or 1K1logK}.

It follows that

𝒰(S(πK,ϖ9),L(πK,ϖ9),I(πK,ϖ9),V(πK,ϖ9),B(πK,ϖ9),Z(πK,ϖ9))+KT(K1logK)(1K1+logK).(28)

Since ab indicates the smallest value of a and b. In view of (27) and , we get

𝒰(S(0),L(0),I(0),V(0),B(0),Z(0))+KTE[IΩK𝒰(S(πK,ϖ9),L(πK,ϖ9),I(πK,ϖ9),V(πK,ϖ9),B(πK,ϖ9),Z(πK,ϖ9))]ε[(K1logK)(1K1+logK)] as K.

This leads to a contradiction, thereby implying that π= almost surely. Hence, the proof is complete.

3  Extinction and Persistence of Disease

In what follows, the criteria for extinction and persistence in the mean are analyzed to better explore the long-term dynamics of the CHIKV system that incorporates inadvertently transmitted viruses and stochastic perturbations controlled by a Poisson random measure. In particular, as time gets closer to infinity, the anticipated outcomes of the resulting constituents are implied to continue to be consistently constrained away from zero by the system’s persistence in mean. On the other hand, disappearance describes the situation in which some compartments, like the transmissible group, asymptotically tend to zero as expected. Using features of the adjusted Poisson integral and stochastic Lyapunov functional components, we obtain sufficient requirements in which the infectious community either dies, disappears, or persists in the mean.

Here, we identify key conditions that favor the eventual eradication of CHIKV within the community. Our primary focus is on the asymptotic behavior of the proposed CHIKV model (4). The analysis begins by formulating a threshold parameter for the system, which serves as a criterion for disease extinction. This threshold provides a quantitative condition under which the infection is expected to die out with high probability. The following result establishes a sufficient criteria for the eradication of the infection in the presence of Poisson random measure:

R0L=βπ(ρ+(1ρ)ϖ3)(ϖ1(ϖ4+ϖ5ϖ6δ))(ϖ2+ϵϖ8ϖ10+σ322)+Φ[Θ3()log(Θ3(x)+1)]t(dΨ).(29)

Theorem 3: Assume that there is a stochastic model (4) possesses the solution (S(t),L(t),I(t),B(t),V(t),Z(t))R+6 having ICs (S(0),L(0),I(0),B(0),V(0),Z(0))R+6. If R0h<1, then the subsequent characteristics of such a model solution must exist:

limtsupS(t)=πϖ1,limtsupL(t)=0,limtsupI(t)=0,limtsupB(t)=ϖ6δ,limtsupV(t)=0,limtsupZ(t)=ϖ8ϖ10.(30)

In simple terms, the above result implies that CHIKV will eventually be eradicated from the population with probability one.

Proof: After performing the integration on model (4), the subsequent formulae can simply be generated:

1t(S(t)S(0))=πϖ1S(t)βS(t)V(t)+σ10tSdB1(t)t+1t0t[Φ[Θ1()S(t)]¯(dt,dΨ)]dt,1t(L(t)L(0))=(1ρ)βS(t)V(t)(Θ+φ)L(t)+σ20tLdB2(t)t+1t0t[Φ[Θ2()L(t)]¯(dt,dΨ)]dt,1t(I(t)I(0))=ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t)+σ30tIdB3(t)t+1t0t[Φ[Θ3()I(t)]¯(dt,dΨ)]dt,

1t(B(t)B(0))=ϖ6+ϖ7V(t)B(t)δB(t)+σ40tBdB4(t)t+1t0t[Φ[Θ4()B(t)]¯(dt,dΨ)]dt,1t(V(t)V(0))=ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t)+σ50tVdB5(t)t+1t0t[Φ[Θ5()B(t)]¯(dt,dΨ)]dt,1t(Z(t)Z(0))=ϖ8+ϖ9I(t)Z(t)ϖ10Z(t)+σ60tZdB6(t)t+1t0t[Φ[Θ6()Z(t)]¯(dt,dΨ)]dt.(31)

Using the fact of (31), one can easily compute

L(t)=1(Θ+φ)(1ρ)βS(t)V(t)1(Θ+φ)(L(t)L(0)t)+1(Θ+φ)(0tσ2L(t)dB2(t)t)+1t0t[ΦΘ2(L)L(t)¯(dt,dΨ)]dt(Θ+φ),=(1ρ)β(Θ+φ)S(t)V(t)+ML(t),(32)

where

ML=1(Θ+φ)(L(t)L(0)t)+1(Θ+φ)(0tσ2L(t)dB2(t)t)+1t0t[ΦΘ2(L)L(t)¯(dt,dΨ)]dt(Θ+φ).(33)

Considering the last formulation of (31), we attain

Z(t)=ϖ8ϖ10+ϖ9ϖ10I(t)Z(t)1ϖ10((Z(t)Z(0))t)+1ϖ10(σ60tZdB6(t)t)+1t0t[Φ[Θ6()Z(t)]¯(dt,dΨ)]dtϖ10,=ϖ8ϖ10+MZ,(34)

whereas

MZ=1ϖ10((Z(t)Z(0))t)+ϖ9ϖ10I(t)Z(t)+1ϖ10(σ60tZdB6(t)t)+1t0t[Φ[Θ6()Z(t)]¯(dt,dΨ)]dtϖ10,(35)

implementing Itô’s technique to the infected human population, the third equation of (31) simplifies to the following form:

dlogI(t)=[ρβS(t)V(t)I(t)+φL(t)I(t)ϖ2ϵZ(t)I(t)I(t)+σ32]dt+σ3dB3(t)Φ[Θ3()log(Θ3(x)+1)]t(dΨ)+Θ[log(Θ3(Ψ)+1)]¯(dt,dΨ).(36)

Applying integration on (36) over (0,t) and dividing by t provides the subsequent relation:

logI(t)t[ρβS(t)V(t)I(t)+φ(1ρ)β(Θ+φ)S(t)V(t)+ML(t)I(t)ϖ2ϵϖ8ϖ10+MZ+σ32]dt+σ3dB3(t)Φ[Θ3()log(Θ3(x)+1)]t(dΨ)+Θ[log(Θ3(Ψ)+1)]¯(dt,dΨ).(37)

By replacing (32) with (37), we find

logI(t)t[ρβS(t)V(t)I(t)+φ(1ρ)β(Θ+φ)S(t)V(t)+ML(t)I(t)+logI(0)tϖ2ϵϖ8ϖ10+MZ+σ32]dt+σ3dB3(t)Φ[Θ3()log(Θ3(x)+1)]t(dΨ)+Θ[log(Θ3(Ψ)+1)]¯(dt,dΨ),dΨ)+σ3dB3(t)t.(38)

Furthermore, Mȷ(t)=aȷt0tdBȷt for ȷ={1,2,,6} are the martingale operator disappears for t=0. Applying t and utilizing Lemma 3, we find

limtsup1t0dMȷt=0.(39)

Whenever R0h<1, (37) generates

limtsuplogI(t)t(ϖ2+ϵϖ8ϖ10+σ322)(R0L1)<0, a.s.(40)

Adopting the same technique, we can prove

limtS(t)=πϖ1,a.s,limtL(t)=0, a.s,limtB(t)=ϖ6δ, a.slimtV(t)=0, a.slimtZ(t)=ϖ8ϖ10.

This yields the intended outcome.

In what follows, we investigate the long-term viability of CHIKV transmission within the general population, specifically under a stochastic framework that incorporates latently infected cells and jump disturbances modeled by a Poisson random measure. To be more precise, we analyze the conditions under which the infection persists, which is a critical prerequisite for designing effective surveillance and control strategies. Our analysis begins with the concept of persistence in the mean, as outlined in [42].

Theorem 4: Assume that the stochastic CHKIV model (4) is perceived as persistent within mean if:

liminftL4(R0Ls1)𝒬1t, a.s,(41)

where

𝒬1=πϖ1+σ122Φ[Θ1(Ψ)log(Θ1(Ψ)+1)]tdΨ(42)

and it ensures that the illness will always occur in the community irrespective of t.

Introducing

R0hs=tx1x2x32.(43)

Proof: Assume that there are functions G1 and G2 for human and reservoir hosts, respectively, defined as:

G1=𝒬1lnS(t)𝒬2lnL(t)𝒬3lnI(t)𝒬4lnV(t),(44)

where 𝒬ζ (ζ=1,2,3,4) are real terms and will be computed later.

Applying the Itô formulation to relation (44), we get

dG1=LG1𝒬1σ1B1(t)𝒬2σ2B2(t)𝒬3σ3B3(t)𝒬4σ4B4(t)𝒬1Φ[Θ1(Ψ)Slog(Θ1(Ψ)+1)]¯(dt,dΨ)𝒬2Φ[Θ2(Ψ)Llog(Θ2(Ψ)+1)]¯(dt,dΨ)𝒬3Φ[Θ3(Ψ)Ilog(Θ3(Ψ)+1)]¯(dt,dΨ)𝒬4Φ[Θ4(Ψ)Vlog(Θ4(Ψ)+1)]¯(dt,dΨ),(45)

LG1=𝒬1lnS(t)𝒬2lnL(t)𝒬3lnI(t)𝒬4lnV(t)=𝒬1πS(t)𝒬1ϖ1𝒬1βV(t)+𝒬1{σ122+Φ[Θ1(Ψ)log(Θ1(Ψ)+1)]tdΨ}𝒬2(1ρ)βS(t)V(t)L(t)𝒬2(Θ+φ)+𝒬2{σ222+Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]tdΨ}𝒬3ρβS(t)V(t)I(t)+𝒬3φL(t)I(t)𝒬3ϖ2𝒬3ϵZ(t)+𝒬3{σ322+Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]tdΨ}.𝒬4ϖ3I(t)V(t)𝒬4ϖ4𝒬4ϖ5B(t)+𝒬4{σ422+Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]tdΨ}(46)

4𝒬1𝒬2𝒬3𝒬4πβ𝒬4ϖ3I(t)+𝒬1{ϖ1+σ122+Φ[Θ1(Ψ)log(Θ1(Ψ)+1)]tdΨ}+𝒬2{Θ+φ+σ222+Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]tdΨ}+𝒬3{ϖ2+σ322+Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]tdΨ}+𝒬4{ϖ8+σ422+Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]tdΨ}.

After simplification, we get

𝒬1=πϖ1+σ122Φ[Θ1(Ψ)log(Θ1(Ψ)+1)]tdΨ,𝒬2=πΘ+Ψ+ϖ10h+σ222Φ[Θ2(Ψ)log(Θ2(φ)+1)]tdΨ,𝒬3=πϖ2+σ322Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]tdΨ,𝒬4=πϖ8+ϕ+σ422Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]tdΨ.

For brevity, assume that

1=ϖ1+σ122Φ[Θ1(Ψ)log(Θ1(Ψ)+1)]tdΨ,2=Θ+φ+σ222Φ[Θ2(Ψ)log(Θ2(Ψ)+1)]tdΨ,3=ϖ2+σ322Φ[Θ3(Ψ)log(Θ3(Ψ)+1)]tdΨ,4=ϖ8+σ422Φ[Θ4(Ψ)log(Θ4(Ψ)+1)]tdΨ.

Utilizing these ȷ, we have

LG14[R0hs1]+𝒬4mI.(47)

Integrating both sides of the stochastic CHIKV model (4) and replacing (47) into (44), we have

G1(S(t),L(t),I(t),V(t))G1(S(0),L(0),I(0),V(0))t=4[R0hs1]+𝒬4mI𝒬1σ1B1(t)𝒬2σ2B2(t)𝒬3σ3B3(t)𝒬4σ4B4(t)𝒬1Φ[Θ1(Ψ)Slog(Θ1(Ψ)+1)]¯(dt,dΨ)𝒬2Φ[Θ2(Ψ)Llog(Θ2(Ψ)+1)]¯(dt,dΨ)𝒬3Φ[Θ3(Ψ)Ilog(Θ3(Ψ)+1)]¯(dt,dΨ)𝒬4Φ[Θ4(Ψ)Vlog(Θ4(Ψ)+1)]¯(dt,dΨ)4[R0hs1]+𝒬4mI1(t).(48)

It follows that

1(t)=𝒬1Φ[Θ1(Ψ)Slog(Θ1(Ψ)+1)]¯(dt,dΨ)t+𝒬2Φ[Θ2(Ψ)Llog(Θ2(Ψ)+1)]¯(dt,dΨ)t+𝒬3Φ[Θ3(Ψ)Ilog(Θ3(Ψ)+1)]¯(dt,dΨ)t+𝒬4Φ[Θ4(Ψ)Vlog(Θ4(Ψ)+1)]¯(dt,dΨ)t.(49)

Applying strong law defined in Lemma 2, we get

limt1(t)=0.(50)

By utilizing Lemma 3, the limit inferior of (48) is provided as:

liminftI4(R0hs1)𝒬4m.(51)

Likewise, liminftI0.

These outcomes constitute the demonstration of Theorem 4. □

4  Near Optimal Control

Preventing CHIKV outbreaks presents numerous challenges, particularly when considering complex biological interactions, latent infection phases, environmental variability, and stochastic perturbations induced by Poisson random measures. These sources of uncertainty can substantially alter disease dynamics, potentially leading to unforeseen outbreaks or the resurgence of infections, even in the presence of ongoing treatment and control efforts.

To address these difficulties, researchers have developed near-optimal control strategies that aim to balance the epidemiological goal of minimizing disease prevalence with the economic and logistical constraints associated with interventions such as vaccination, antiviral treatment, and vector control (see [30]). Within this framework, we explore the near-optimality criteria of a stochastic control system modeled by a continuous-time Markov chain, where the evolution of the system is influenced by both continuous fluctuations (e.g., Brownian motion) and discrete, abrupt changes (e.g., Poisson-driven jumps).

This probabilistic modeling approach not only provides a more realistic representation of sudden events—such as mass vaccination campaigns or unexpected environmental changes—but also facilitates the application of stochastic control techniques, particularly through recursive optimization and the Hamilton-Jacobi-Bellman (HJB) framework (see [30]). As a result, it enables the formulation of robust, adaptive intervention policies that perform effectively under uncertainty, offering valuable insights for public health policy, epidemic mitigation, and strategic planning in the context of CHIKV. The system of SDEs under near-optimal control is defined as

dSt=(π(Λt)ϖ1(Λt)Stβ(Λt)StVtϖ2k(Λt)ωtSt)dt+κ1(Λt)StdB(t)+Lg(t,Λt,St,ωt,ϑ)¯k(dt,dϑ),St0=S0,dLt=((1ρ(Λt))β(Λt)StVt(Θ(Λt)+φ(Λt))Ltϖ2k(Λt)ωtLt)dt+κ2(Λt)LtdB(t)+Lg(t,Λt,Lt,ωt,ϑ)¯k(dt,dϑ),Lt0=L0,dIt=(ρ(Λt)β(Λt)StVt+φ(Λt)Ltϖ2(Λt)Itϵ(t)ItZtϖ2k(Λt)ωtI)dt+κ3(Λt)ItdB(t)+Lg(t,Λt,It,ωt,ϑ)¯k(dt,dϑ),Vt0=V0,

dVt=(ϖ3(Λt)I(t)ϖ4(Λt)ωtϖ5(Λt)ωtBtϖ2k(Λt)ωtV)dt+κ4(Λt)VtdB(t)+Lg(t,Λt,Vt,ωt,ϑ)¯k(dt,dϑ),Vt0=V0,dBt=(ϖ6(Λt)+ϖ7(Λt)ωtBtδ(Λt)Btϖ2k(Λt)ωtBt)dt+κ5(Λt)BtdB(t)+Lg(t,Λt,Bt,ωt,ϑ)¯k(dt,dϑ),Bt0=B0,dZt=(ϖ8(Λt)+ϖ9(Λt)ItZtϖ10(Λt)Ztϖ2k(Λt)ωtZt)dt+κ6(Λt)ZtdB(t)+Lg(t,Λt,Zt,ωt,ϑ)¯k(dt,dϑ),It0=I0.(52)

Thanks to Kuang et al. [48], we describe the corresponding objective function as:

J(0,Υ0,ωt)=E[0^h~(t,Λt,Υt,ωt)dt+h^(Λ^,Υ^)],(53)

h~(t,Λt,Υt,ωt)=E[0^(C1St+C2Lt+C3It+C4Vt+C5Bt+C6Zt+ϖ2kωt2)dt],h^(Λ^,Υ^)=(0,0,It(Λt),0,0),(54)

containing h~:[0,^]×𝒮×Rn×Uad[0,^]Rn and h^:𝒮×RnR.

Lemma 6: Imagine F, the predictable κ-field on ρ×[0,^], where (t,ϑ) is a F×𝒵(Y) measurable and fulfills

E[0^L|σ(t,ϑ)|2ϖ8(dϑ)dt]<+,(55)

then a fixed positive constant C>0, for each m 2 that

E{supt[0,^]||0^Yσ(t,ϑ)(dt,dϑ)||m}CE{0^L|σ(t,ϑ)|mϖ8(dϑ)dt}.(56)

To support the analysis, we introduce the subsequent assumptions:

(A1): The functions σ=ϖ7,ξ,h~ are continuously differentiable related to Υt and a fixed C>0 such that:

||σ(t,Λt,Υt,ωt)||+supϑY||g(t,Λt,Υt,ωt,ϑ)||C(1+||Υt||+||ωt||),||σ(t,Λt,Υt,ωt)σ(t,Λt,Υ~t,ωt)||+supϑY||g(t,Λt,Υt,ωt,ϑ)g(t,Λt,Υ~t,ωt,ϑ)||C|ΥtΥ~t|,||σΥ(t,Λt,Υt,ωt)σΥ(t,Λt,Υ~t,ωt)||+supϑY||gΥ(t,Λt,Υt,ωt,ϑ)gΥ(t,Λt,Υ~t,ωt,ϑ)||C|ΥtΥ~t|.

(A2): Ensure that h^ be a convex and continuously differentiable function with regard to Υt and also bounded by C(1+||Υt||), it follows that a constant C> 0 and

||h^(Λt,Υt)h^(Λt,Υ~t)||+||h^Υ(Λt,Υt)h^(Λt,Υ~t)||C||Υt,Υ~t||.(57)

(A3): The functions σ=ϖ7,ξ,h~ are differentiable with regard to V and a constant C>0 such that:

||σ(t,Λt,Υt,ωt)σ(t,Λt,Υt,V~t)||+supϑY||g(t,Λt,Υt,ωt,ϑ)g(t,Λt,Υt,ω~t,ϑ)||C||ωtω~t||,||σω(t,Λt,Υt,ωt)σω(t,Λt,Υt,ω~t)||+supϑY||gω(t,Λt,Υt,ωt,ϑ)gu(t,Λt,Υt,ω~t,ϑ)||C||ωtω~t||.(58)

Remark 1: Under the assertions (A1)(A3), standard arguments establish that a pair of constants r and C achieving

E{sup0t^||Υt||r}C.(59)

Remark 2: For any ωtUad[0,^], formulation (52) possesses only one adapted solution Υt. Thus, (Υt,ωt) is designated as an admissible pair.

4.1 Adjoint Equation and Related Outcomes

Adjoint equations and pretreatment assessments are essential for the analysis and solution of optimal control challenges in stochastic mechanisms, especially those that simulate CHIKV evolution, including inactivated infections and jump dynamics. When processes are affected by stochastic components like Wiener procedures, Poisson random measures, or Markov chains, these methods are essential for determining the factors required for optimality. Adjoint equations, which are frequently expressed as backward SDEs, are essential for describing optimum strategies in the context that the stochastic maximum principle (SMP) offers for these kinds of analysis [30].

Applying jump dynamics through Poisson random effects into CHIKV systems makes it possible for better representation of unexpected alterations in the environment or interventional tactics, including widespread vaccination programs. To investigate fundamental claims, estimations, and categorization of these frameworks, the adjoint formulae obtained within this context are essential. Previous studies have demonstrated their significance (see [30]).

To confirm and strengthen the adjoint equations within the CHIKV model (4), we provide initial findings demonstrating their usefulness and well-posedness. In addition, we present a Hamiltonian function that is specific to our stochastic structure, which sheds light on the changing behavior of the system and makes it easier to derive near-optimal control schemes. In addition to improving our comprehension of infectious processes, this method helps create successful approaches to treatment in the face of ambiguity. Additionally, a Hamiltonian function is introduced for the first time to provide further insights into the dynamics and framework of the problem is stated as:

H:[0,^]×𝒮×Rn×Uad[0,^]×Rn×Rn×RnR,(60)

which is Fréchet differentiable space and linear convexity in the Υt and ωt arguments, thus we have

H(t,Λt,Υt,ωt,f1(t),f2(t),σ(t,ϑ))=ϖ7(t,Λt,Υt,ωt)f1(t)+ξ(t,Λt,Υt,ωt)f2(t)+Yg(t,Λt,Υt,ωt,ϑ)σ(t,ϑ)ϖ8(dϑ)+h~(t,Λt,Υt,ωt),(61)

where

ϖ7(t,Λt,Υt,ωt)=[πϖ1S(t)βS(t)V(t)(1ρ)βS(t)V(t)(Θ+φ)L(t)ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t)ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t)ϖ6+ϖ7V(t)B(t)δB(t)ϖ8+ϖ9I(t)Z(t)ϖ10Z(t)],ξ(t,Λt,Υt,ωt)=[κ1(Λt)S(t)dB(t)κ2(Λt)L(t)dB(t)κ3(Λt)I(t)dB(t)κ4(Λt)V(t)dB(t)κ5(Λt)B(t)dB(t)κ6(Λt)Z(t)dB(t)],h~(t,Λt,Υt,ωt)=[h~(t,Λt,S(t),ωt)h~(t,Λt,L(t),ωt)h~(t,Λt,I(t),ωt)h~(t,Λt,V(t),ωt)h~(t,Λt,B(t),ωt)h~(t,Λt,Z(t),ωt)],g(t,Λt,Υt,ωt)=[g(t,Λt,S(t),ωt)g(t,Λt,L(t),ωt)g(t,Λt,I(t),ωt)g(t,Λt,V(t),ωt)g(t,Λt,B(t),ωt)g(t,Λt,Z(t),ωt)].(62)

Let ϖ7, ρ and g be functions defined as follows:

•   ϖ7:[0,^]×𝒮×Rn×Uad[0,^]Rn,

•   ρ:[0,^]×𝒮×Rn×Uad[0,^]Rn,

•   g:[0,^]×𝒮×Rn×Uad[0,^]Rn.

Here, the continuous-time Markov chain Λt for the state space 𝒮={1,2,,N} and ωt is the control variable, which takes terms in the feasible control collection Uad[0,^]. For simplicity, the state vector is represented as:

Υ(t)=[St,Lt,It,Vt,Bt,Zt].(63)

We could also add the subsequent boundary value problems to a backward SDE [48] as it gives a way to derive its first-order adjoint equation. It is more advantageous to portray (52) as

df11(t)={(π(Λt)ϖ1(Λt)S(t)β(Λt)S(t)V(t)ϖ2k(Λt)ωtS(t)gS(t)+YgS(t)σ(t,ϑ)ϖ8(dϑ)+h~S(t))dtf1(t)+κ1(Λt)S(t)dB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),f11(^)=S(t)h^(S(t)^,Λ^),df12(t)={((1ρ)β(Λt)StV(t)(Θ(Λt)+φ(Λt))Ltϖ2k(Λt)ωtL(t)gS(t)+YgL(t)σ(t,ϑ)ϖ8(dϑ)+h~L(t))dtf1(t)+κ2(Λt)L(t)dB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),f12(^)=L(t)h^(L(t)^,Λ^),df13(t)={(ρ(Λt)β(Λt)S(t)V(t)+φ(Λt)L(t)ϖ2(Λt)I(t)ϵ(t)I(t)Z(t)gS(t)ϖ2k(Λt)ωtI(t)+YgItσ(t,ϑ)ϖ8(dϑ)+h~It)dtf1(t)+κ3(Λt)ItdB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),f13(^)=I(t)h^(I(t)^,Λ^),

df14(t)={(ϖ3(Λt)I(t)ϖ4(Λt)ω(t)ϖ5(Λt)ω(t)Btϖ2k(Λt)ωtV(t)gS(t)+YgVtσ(t,ϑ)ϖ8(dϑ)+h~Vt)dtf1(t)+κ4(Λt)VtdB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),f14(^)=V(t)h^(V(t)^,Λ^),df15(t)={(ϖ6(Λt)+ϖ7(Λt)ω(t)B(t)δ(Λt)B(t)ϖ2k(Λt)ωtB(t)gS(t)+YgB(t)σ(t,ϑ)ϖ8(dϑ)+h~B(t))dtf1(t)+κ5(Λt)B(t)dB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),f15(^)=B(t)h^(B(t)^,Λ^),

df16(t)={(ϖ8(Λt)+ϖ9(Λt)I(t)Z(t)ϖ10(Λt)Z(t)ϖ2k(Λt)ωtZ(t)gS(t)+YgZ(t)σ(t,ϑ)ϖ8(dϑ)+h~Z(t))dtf1(t)+κ6(Λt)Z(t)dB(t)f2(t)+Yσ(t,ϑ)¯(dt,dϑ)+(t)dω~(t),crf16(^)=Z(t)h^(Z(t)^,Λ^).(64)

By defining the vector (t)=[1(t),,n(t)], where each k(t) belongs to RN×N, with k=1,,n. Additionally, ΥH denotes the gradient of the function H with respect to Υt.

We introduce the following representation for (t):

(t)dω~(t)=[kȷji1dω~ji(t),,kȷjindω~ji(t)].(65)

The given analysis supports the derivation in [49]. Assuming the validity of assertions (A1) to (A3), the presence of singular outcomes for (f1(t),f2(t),(t),σ(t,ϑ)) to the 1st order adjoint system (64) is established in [50]. This may be illustrated as follows. We create two metrics, d and d~, on the collection Uad[0,^]. in view of two control processes ωt and ω~t:

d(ωt,ω~t)=f1~{(t,q1)[0,^]×Ω:ω(t,q1)ω~(t,q1)},(66)

d~(ωt,ω~t)=E0^(1+f1ϵ(t)+f2ϵ(t)+supϑYϕϵ(t,ϑ))ωtω~tdt,(67)

where the multiplicative measure of Lebesgue measure f1 is denoted by f1~.

For a closed convex subset U of Rm, it follows that Uad comprises a complete metric space concerning to the metrics d and d~, as established in [51].

Theorem 5: It is assumed in the event that the assertions (A1)(A3) are met. In such a scenario, the Eq. (64) has only one solution (f1(t),f2(t),(t),σ(t,ϑ)) satisfying:

E{sup0t^f1(t)2+0^[f1(t)2+(t)21{Λ(t)=ȷπij}+Yσ(t,ϑ)2q2(dς)]dt}C.(68)

This theorem is proven using an identical approach to the results established in [50,51], and is therefore omitted for brevity.

Theorem 6: Given that the assertions (A1)(A3) are fulfilled. In this situation, all the optimal strategies ωt,ω~tUad[0,^] together with the corresponding solutions Υt,Υ~t of framework (52), there is a non-negative number C for which:

Esupt[0,^]||ΥtΥ~t||2ΨCd(ωt,ω~t)Ψϑ,Ψ0,0<ϑ<1,Ψϑ<1.(69)

Proof: By optimizing and applying integration over (0,r) on systems (52), we have

Υ(r)Υ(0)=0rϖ7(t,Λt,Υt,ωt)dt+0rξ(t,Λt,Υt,ωt)dB(t)+0rYg(t,Λt,Υt,ωt,ϑ)¯~(dt,dϑ).(70)

For Ψ1, conclude that

E||ΥrΥ~r||2ΨC1E0rY(g(t,Λt,Υt,ωt,ϑ)g(t,Λt,Υ~t,ω~t,ϑ))N~(dt,dϑ)||2Ψ+C1E0r(ξ(t,Λt,Υt,ωt)ξ(t,Λt,Υ~t,ω~t))dB(t)2Ψ+C1E0r(ϖ7(t,Λt,Υt,ωt)ϖ7(t,Λt,Υ~t,ω~t))dt2Ψ.(71)

Using the fact of [52], we get

Esupt[0,r]ΥtΥ~t2ΨC2E0rYg(t,Λt,Υt,ωt,ϑ)g(t,Λt,Υ~t,ω~t,ϑ)2Ψq2(dϑ)dt+C2E0rξ(t,Λt,Υt,ωt)ξ(t,Λt,Υ~t,ω~t2Ψdt+C1E0r(ϖ7(t,Λt,Υt,ωt)ϖ7(t,Λt,Υ~t,ω~t))dt2Ψ.(72)

As a result of Hölder’s inequality and Cauchy-Schwarz, we get:

Esupt[0,^]ΥtΥ~t2ΨC3E0^Yg(t,Λt,Υt,ω~t,ϑ)g(t,Λt,Υt,ω~t,ϑ)2Ψq2(dϑ)dt+C3E{0^ϖ7(t,Λt,Υt,ω~t)ϖ7(t,Λt,Υt,ω~t)2Ψ1ωtω~tdt}+C3E{0^ϖ7(t,Λt,Υt,ω~t)ϖ7(t,Λt,Υ~t,ω~t)2Ψdt}+C3E{0^ξ(t,Λt,Υt,ωt)ξ(t,Λt,Υ~t,ω~t)2Ψdt}.(73)

Utilizing (A1) and 1ρΨ>1, Hölder’s inequality yields

E0^ϖ7(t,Λt,Υt,ωt)ϖ7(t,Λt,Υt,ω~t)2Ψ1{ωtω~t}dtE{0^ϖ7(t,Λt,Υt,ωt)ϖ7(t,Λt,Υt,ω~t)2Ψ(1Ψρ)dt}1ΨρE{0^1{ωtω~t}dt}ΨρC4E{0^(1+Υt+ωt+ω~t)2Ψ(1Ψρ)dt}1ΨρE{0^1{ωtω~t}dt}Ψρ.(74)

In view of (74) and observing Remark 2, we have

Esupt[0,^]ΥtΥ~t2ΨC5{E0^1ωtω~tdt}Ψρ+C5E0^ΥtΥ~t2Ψdt.(75)

Making the use of Bellman-Grönwall inequality, yields

Esupt[0,^]ΥtΥ~t2ΨCE{0^1ωtΥ~tdt}Ψρ=Cd(Υt,Υ~t)Ψρ.(76)

Employing the Cauchy-Schwarz variant, we can conclude that 0Ψ<1.

Esupt[0,^]ΥtΥ~t2Ψ{Esupt[0,^]ΥtΥ~t2}Ψ{Cd(ωt,ω~t)ρ}Ψ=Cd(ωt,ω~t)ρΨ.(77)

This finalizes the demonstration.

Theorem 7: Under the hypotheses (A1)(A3) hold. Then, not only for tenable couplets (ωt,Υt), (ω~t,Υ~t) as well as the associated adjoint processes (f1(t),f2(t),σ(t,ϑ)) and (~1(t),~2(t),~(t),ϑ~(t,ς)), constants Ψ(1,2), ρ(0,1), (1+ρ)<2/Ψ and C>0 ensuring that:

E0^(f1f1~Ψ+f2f2~Ψ+tt~Ψ1Λ(t)=iπij+Yϑϑ~Ψq2(dς))dtCd(ωt,ω~t)Ψρ.(78)

Proof: By presupposing the following notations to be used in this section.

f1¯=f1(t)f1~(t),f2¯=f2(t)f2~(t),¯=(t)~(t),ϑ¯(t,ς)=σ(t,ϑ)ϑ~(t,ς).(79)

The following backward SDE is then satisfied by (f1,f2,,ϑ):

df1¯(t)={[rΥ(t,Λt,Υt,ωt)f1¯+ξΥ(t,Λt,Υt,ωt)f2¯]dt[YgΥ(t,Λt,Υt,ωt,ς)ϑ¯(t,ς)q2(dς)+(t)]dt+f2¯dB(t)+Yϑ¯(t,ς)¯(dt,dς)+¯dω~(t),(80)

with the boundary condition:

f1¯(^)=h^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^).(81)

The factor (t) is presented as:

(t)={[rΥ(t,Λt,Υt,ωt)rΥ(t,Λt,Υ~t,ω~t)]f1~(t)+[ξΥ(t,Λt,Υt,ωt)ξΥ(t,Λt,Υ~t,ω~t)]f2~(t)+Y[gΥ(t,Λt,Υt,ωt,ς)gΥ(t,Λt,Υ~t,ω~t,ς)]ϑ~(t,ς)q2(dς)+[h~Υ(t,Λt,Υt,ωt)h~Υ(t,Λt,Υ~t,ω~t)].(82)

Additionally, by stating a SDE with ϑ~=ϑ~(t,ς)

dP(t)={[rΥ(t,Λt,Υt,ωt)P¯(t)+f1¯Ψ1sgn(f1¯)]dt+[ξΥ(t,Λt,Υt,ωt)P(t)+f2¯Ψ1sgn(f2¯)]dB(t)+Y[gΥ(t,Λt,Υt,ωt,ς)P(t)+ϑ¯Ψ1sgn(ϑ¯)](dt,dς)+¯Ψ1sgn(¯)dω~(t),f11(0)=0,(83)

where sgn(f11¯)=(sgn(f1¯11),sgn(f1¯12),sgn(f1¯13),,sgn(f1¯1n)) represents the sign function for the vector f11¯. On the behalf of the fact that rΥ, ξΥ and gΥ are bounded and by the following

E0^[f11¯Ψ1sgn(f11¯)2+f2¯Ψ1sgn(f2¯)2+¯Ψ1sgn(¯)2]dt+E0^Yϑ¯Ψ1sgn(ϑ¯)2q2(dς)dt<,(84)

the solution of (83) can be verified by checking the existence-uniqueness of outcome similar to (73), for ΨΨ1>2, yields

Esupt[0,^]P(t)ΨΨ1C1E0^YgΥ(t,Λt,Υt,ωt,ς)P(t)+ϑΨ1sgn(ϑ)ΨΨ1q2(dς)dt+C1E0^rΥ(t,Λt,Υt,ωt)P(t)+f11¯Ψ1sgn(f11¯)ΨΨ1dt+C1E0^ξΥ(t,Λt,Υt,ωt)P(t)+f2¯Ψ1sgn(f2¯)ΨΨ1dt+C1E0^[(t)Ψ1sgn((t))]ΨΨ11Λ(t)=ȷπijdt.(85)

Lemma 4 and the boundedness of rΥ, ξt and gΥ may be used to obtain

Esupt[0,^]f11(t)ΨΨ1C2E0^[f1¯Ψ+f2¯Ψ+tΨ1Λ(t)=ȷπij+YϑΨq2(dς)]dt+C2E0^P(t)ΨΨ1dt.(86)

The Bellman-Gronwall variant allows us to write

Esupt[0,^]P(t)ΨΨ1S:=C3E0^[f11¯Ψ+f2¯Ψ+¯Ψ1Λ(t)=ȷπij+YϑΨq2(dς)]dt.(87)

It is follow that

E[f11¯(^)P(^)]=E0^f11¯[(rΥ(t,Λt,Υt,ωt))P(t)+f11Ψ1sgn(f1¯)]dt+E0^P(t)[(rΥ(t,Λt,Υt,ωt))f11¯+f11Ψ1sgn(f11¯)+ξΥ(t,Λt,Υt,ωt)]dt+E0^f11(t)[YgΥ(t,Λt,Υt,ωt,ς)q2(dϑ)+(t)]dt+E0^f2[(ξ(t,Λt,Υt,ωt))P(t)+f2Ψ1sgn(f2¯)]dt+E0^Yϑ¯(t,ϑ)[gΥ(t,Λt,Υt,ωt,ς)P(t)+ϑΨ1sgn(ϑ)]q2(dϑ)dt+E0^¯¯Ψ1sgn(¯)dt.(88)

It is worth-mentioning that

E[f11¯(^)P(^)]=E0^(f11¯f11¯Ψ1sgn(f11¯)+¯tΨ1sgn(¯)+f2¯f2¯Ψ1sgn(f2¯))dt+E0^YϑϑΨ1sgn(ϑ)q2(dϑ)dtE0^P(t)(t)dt=E0^[f11¯Ψ+f2¯Ψ+¯Ψ+1Λ(t)=ȷπij+YϑΨq2(dϑ)]dtE0^P(t)(t)dt.(89)

Thus, we have

E[f11¯(^)P(^)]+E0^P(t)(t)dtE[0^(t)Ψdt]1ΨE[0^P(t)ΨΨ1dt]11Ψ+E[h^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)]P(^).(90)

Consequently, we have

E[P¯(^)f1(^)]+E0^f1(t)(t)dtC4SΨ1Ψ[Eh^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)Ψ]1Ψ+C4SΨ1ΨE[0^(t)Ψdt]1Ψ.(91)

After a straight-forward computation, observe that

E[f11¯(^)P¯(^)]=E0^(f11f11Ψ1sgn(f11)+t¯Ψ1sgn(¯)+f2f2Ψ1sgn(f2))dt+E0^Yϑϑ¯Ψ1sgn(ϑ¯)q2(dϑ)dtE0^P(t)(t)dt=E0^[f11¯Ψ+f2¯Ψ+¯Ψ+1Λ(t)=ȷπȷ+Yϑ¯Ψq2(dϑ)]dtE0^f1(t)(t)dt.(92)

Moreover, applying Hölder inequality we have

E[f11(^)P(^)]+E0^P(t)(t)dtE[(0^(t)Ψdt)1Ψ]E[(0^f1(t)Ψ(Ψ1)dt)11Ψ]+E[h^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)]P(^).(93)

Utilizing (87) into (93), we attain:

E[f11(^)P(^)]+E0^P(t)(t)dtC4SΨ1ΨE[h^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)Ψ]1Ψ+C4SΨ1ΨE[(0^(t)Ψdt)1Ψ].(94)

Referring to (94) and observing Remark (59), one can write

Esupt[0,^]ΥtΥ~t2ΨC5{E0^1ωtω~tdt}Ψρ+C5E0^ΥtΥ~t2Ψdt.(95)

Combining (87), (92) and (95), we have

SC5Eh^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)Ψ+C6E0^(t)Ψdt.(96)

From (A2) and Theorem 6, we can get

Eh^Υ(Λ^,Υ^)h^Υ(Λ^,Υ~^)ΨC7EΥ^Υ~^ΨC8d(ωt,ω~t)Ψρ2.(97)

It follows that

E0^(t)ΨdtC9E0^YgΥ(t,Λt,Υt,ωt)gΥ(t,Λt,Υ~t,ω~t)Ψϕ~(t,ϑ)Ψq2(dϑ)dt+C9E0^rΥ(t,Λt,Υt,ωt)rΥ(t,Λt,Υ~t,ωt)Ψf1~(t)Ψdt+C9E0^ξΥ(t,Λt,Υt,ωt)ξΥ(t,Λt,Υt,ω~t)Ψf2~(t)Ψdt+C9E0^ξΥ(t,Λt,Υt,ω~t)ξΥ(t,Λt,Υ~t,ω~t)Ψf2~(t)Ψdt+C9E0^h~Υ(t,Λt,Υt,ωt)h~Υ(t,Λt,Υ~t,ωt)Ψdt+C9E0^h~Υ(t,Λt,Υ~t,ωt)h~Υ(t,Λt,Υ~t,ω~t)Ψdt.(98)

For 2Ψ>1, we can deduce by the Hölder inequality and the assertions (A1)(A3) that

0^ξΥ(t,Λt,Υt,ωt)ξΥ(t,Λt,Υt,ω~t)Ψf2~(t)Ψdt+0^ξΥ(t,Λt,Υt,ω~t)ξΥ(t,Λt,Υ~t,ω~t)Ψf2~(t)ΨdtC10E{(0^1ω^ω~t2Ψ2Ψdt)1Ψ2}E{(0^f2~(t)2dt)Ψ2}+C10E{(0^Υ^Υ~t2Ψ2Ψdt)1Ψ2}E{(0^f2~(t)2dt)Ψ2}.(99)

Thanks to d(ωt,ω~t)1 and (1+ρ)Ψ<2, we get

E{(0^1ωtω~t2Ψ2Ψdt)1Ψ2}=d(ωt,ω~t)1Ψ2d(ωt,ω~t)Ψρ/2.(100)

Furthermore, it is straightforward to verify that 2Ψ2Ψ>2, therefore by Theorem 6, we have

E{(0^Υt,Υ~t2Ψ2Ψdt)1Ψ2}C11d(ωt,ω~t)Ψρ/(2Ψ)C11d(ωt,ω~t)Ψρ/2.(101)

By implementing Theorem 5 and putting (100) and (101) into (99), we may achieve

0^{ξΥ(t,Λt,Υt,ωt)ξΥ(t,Λt,Υt,ω~t)Ψ+ξΥ(t,Λt,Υt,ω~t)ξΥ(t,Λt,Υ~t,ω~t)Ψ}f2~(t)ΨdtC12d(ωt,ω~t)Ψρ/2.(102)

Analogously, we have

E0^(t)ΨdtC13d(ωt,ω~t)Ψρ/2.(103)

The proof that completes the given work can be derived from combining equations (87), (96), (97) and (103).

4.2 Sufficiency Criteria of Near-Optimality

To effectively implement countermeasures against CHIKV outbreaks, it is essential to establish sufficient conditions under which surveillance and intervention strategies achieve near-optimality. This becomes particularly important when accounting for the accelerated transmission dynamics caused by an undetected latent phase and the inherent randomness introduced via Poisson random measures. The inclusion of latently infected compartments introduces additional variability into the system, while Poisson jumps are employed to model abrupt and spontaneous events—such as emergency public health campaigns (e.g., mass vaccination or intensified vector control) or sudden infestations.

However, the system dynamics are governed by a set of SDEs driven jointly by Brownian motion and Poisson random measures, with a cost functional designed to minimize both the disease burden and the cost of interventions over a finite time horizon.

These conditions ensure that, even in the presence of random outbreaks (Poisson perturbations) and latent dynamics, a control strategy—while not exactly optimal—remains effectively close to the optimal policy in terms of cost and outcome. Such frameworks are critical for designing robust intervention strategies that account for delays in infection, stochastic shocks, and cost constraints, ultimately enhancing epidemic preparedness and control for CHIKV.

We now turn our attention to presenting one of the key results of this study: a sufficient condition, as expressed in (52), under which the proposed control qualifies as a stochastic near-optimal strategy.

Theorem 8: Assume that the assertions (A1)(A3) hold; for any ϵ >0 and suppose that (Υtϵ,ωtϵ) considered to be same for any admissible pair of (f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)) and the corresponding adjoint equation has a solution such as

E0^H(t,Λt,Υtϵ,ωtϵ,f1ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dtinfωtUad[0,^]E0^H(t,Λt,Υtϵ,ωt,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dt+ϵ,(104)

consequently, a positive constant C exists that satisfies

J(0,Υ0,ωtϵ)infωtUad[0,^]J(0,Υ0,ωt)+Cϵ12.(105)

Proof: To begin with, we present the following useful result

W(ω)=H(t,Λt,Υtϵ,ωtϵ,f1ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)).(106)

It is evident that

W(ω)W(ωϵ)=0^[ϖ7(t,Λt,Υtϵ,ωt)ϖ7(t,Λt,Υtϵ,ωtϵ)]f11ϵ(t)d(t)+0^[ξ(t,Λt,Υtϵ,ωt)ξ(t,Λt,Υtϵ,ωtϵ)]f2ϵ(t)d(t)+0^Y[g(t,Λt,Υtϵ,ωt,ϑ)g(t,Λt,Υtϵ,ωtϵ,ϑ)]σϵ(t,ϑ)q2(dϑ)+0^[h~(t,Λt,Υtϵ,ωt)h~(t,Λt,Υtϵ,ωtϵ)].(107)

According to (A3), we attain

W(ω)W(ωϵ)=0^ϖ7(t,Λt,Υtϵ,ωt)ϖ7(t,Λt,Υtϵ,ωtϵ)f1ϵ(t)d(t)+0^ξ(t,Λt,Υtϵ,ωt)ξ(t,Λt,Υtϵ,ωtϵ)f2ϵ(t)d(t)+0^Yg(t,Λt,Υtϵ,ωt,ϑ)g(t,Λt,Υtϵ,ωtϵ,ϑ)σϵ(t,ϑ)q2(dϑ)+0^h~(t,Λt,Υtϵ,ωt)h~(t,Λt,Υtϵ,ωtϵ)CE0^(1+f11ϵ(t)+f2ϵ(t)+supϑYσϵ(t,ϑ))ωtωtϵdt=Cd(ωt,ωtϵ).(108)

Here, operator W supposed to be a continuous on Uad[0,^] through the metric d. By means of (104) and the Ekeland variational concept [46], a control process ω~tϵ can be identified. The derived ω~tϵUad[0,^] is proven to be adequate

d(ω~tϵ,ωtϵ)ϵ12(109)

and

E0^H(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dtinfωtUad[0,^]E0^H(t,Λt,Υtϵ,ωt,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dt+d(ω~t,ωtϵ)ϵ12.(110)

From this, we deduce that

E0^H~(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dtE0^H~(t,Λt,Υtϵ,ωt,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dt,(111)

where

E0^H~(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dt=E0^H(t,Λt,Υtϵ,ωt,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))dt+Z(t)ω~tϵ,ωtϵ(112)

and

Z(t)=1+f11ϵ(t)+f2ϵ(t)+supϑYσϵ(t,ϑ)1.(113)

Therefore, we have

H~(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))=minω^Uad[0,T]H~(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)).(114)

By leveraging the finding from [46] and utilizing the property that the adapted gradient of a sum is contained within the sum of the adapted gradients, it follows that:

0ωH~(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))ωH(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))+[ϵ12Zϵ(t),ϵ12Zϵ(t)].(115)

Therefore, it is possible to select ϖ10(t) in such a way that

Hω(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))+ϖ10(t)=0,ϖ10(t)[ϵ12Zϵ(t),ϵ12Zϵ(t)].(116)

Furthermore, utilizing the aforesaid formulation and the assertion (A3), which leads to

Hω(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))Hω(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))+Hω(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))Hω(t,Λt,Υtϵ,ω~tϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))ϵ12zϵ(t)+C(1+f11ϵ(t)+f2ϵ(t)+supϑYϕϵ(t,ϑ))ωtϵω~tϵ.(117)

Since the operator H(t,Λt,Υt,ωt,f11(t),f2(t),σ(t,ϑ)) is convex with respect to Υt,ωt, integrating both sides leads to the conclusion that:

0^H(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)(t,ϑ))H(t,Λt,Υt,ωt,f11ϵ(t),f2ϵ(t),σϵ(t,ϑ))dt0^HΥ(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))(HtϵΥt)dt+0^HΥ(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ))(ωtϵωt)dt.(118)

Taking the expectation on both sides of (118) and merging (109) and (117), we attain

E0^H(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)(t,ϑ))H(t,Λ^,Υ^,ω^,f11ϵ(t),f2ϵ(t),ϕϵ(t,ϑ))dtE0^HΥ(t,Λt,Υtϵ,ωtϵ,f11ϵ(t),f2ϵ(t),σϵ(t,ϑϵ)(t,ϑ))(Υ^ϵΥ^)dt+Cϵ12.(119)

Due to the convexity of the function h^(Λ^,Υ^), we get

E[h^(Λ^,Υ^ϵ)h^(Λ^,Υ^)]E[h^Υ(Λ^,Υ^ϵ)(Υ^ϵΥ^)]=E[f11ϵ(t)(Υ^ϵΥ^)].(120)

Employing Lemma 3.2 from [46], it is straightforward to get

E[f11ϵ(t)(Υ^ϵΥ^)]=0^Y[ϕϵ(t,ϑ)][g(t,Λ^,Υtϵ,ωtϵ,ϑ)g(t,Λ^,Υt,ωt,ϑ)]q2(dϑ)dt+E0^[f11ϵ(t)][ϖ7(t,Λ^,Υ^ϵ,ωtϵ)ϖ7(t,Λ^,Υ^,ω^)]dt+E0^[f2ϵ(t)][ξ(t,Λ^,Υ^ϵ,ωtϵ)ξ(t,Λ^,Υ^,ω^)]dt.(121)

Consequently, from (119)(121), we deduce that

J(0,Υ0,ωtϵ)J(0,Υ0,ω^)+Cϵ12.(122)

As ω^ is arbitrary. This concludes the proof.

Remark 3: To establish Theorem 8, the function H() must be nearly maximized in its integral form. Furthermore, we can conclude that the ϵ-maximal scenario for the operator H(t,rt,Xt,ωt,f11(t),f2(t),σ(t,ϑ)) implies near-optimality having an error estimate of order ϵ12.

4.3 Necessary Criterion for Near-Optimal Control

A comprehensive stochastic control strategy is developed by the investigation of the required threshold for near-optimal control of the CHIKV framework (4), which incorporates inadvertent infectious people and is influenced by a Poisson random measure. To precisely represent rapid and unpredictable variations in infectious disease behavior, including unexpected eruptions or interventional impact, this framework employs SDEs featuring jump transitions. In order to minimize a cost criterion that normally weighs operational costs vs. public health objectives, control measures like vaccination or vector elimination are implemented.

Ekeland’s variational concept [46] is used to determine the requirements for near-optimality, guaranteeing the presence of nearly optimal controls and permitting a variational evaluation [53]. As a result, a Hamiltonian function is constructed and adjoint mechanisms are introduced, enabling the formulation of a variational inequality. The main finding is that, in comparison to all other permissible controls, the predicted Hamiltonian under a given condition must be almost maximal—within a small error margin—in order for it to be deemed near-optimal. To operate CHIKV effectively and efficiently in the face of unpredictability, this approach offers essential perspectives.

Here, in order to explain the essential assertions of the near-optimal control problem associated with system (52), it follows that any near-optimal control must satisfy a corresponding necessary maximum principle, with an error of order ϵι2(1ι2) at some intermediate point, where ι[0,12].

Theorem 9: Assume that (Υtϵ,ωtϵ) denote a valid control pair and let (f11ϵ(t),f2ϵ(t),ϵ(t),σϵ(t,ϑ)) be the solution to the adjoint equation for some arbitrary ϵ >0. Then constants such that 0<Ψ<1, 1<ρ<2 and (1+Ψ)ρ<2 having a positive constant C>0 and a parameter ι lies in [0,12], which satisfy the following conditions:

Cϵι2(1ι2)E0^Y[ϕϵ(t,ϑ)][g(t,ωt,Υtϵ,ωt,ϑ)g(t,Λt,Υtϵ,ωtϵ,ϑ)]q2(dϖ1)dt+E0^[qϵ(t)][ξ(t,Λt,Υtϵ,ωt)ξ(t,Λt,Υtϵ,ωtϵ)]dt+E0^[f11ϵ(t)][ϖ7(t,Λt,Υtϵ,ωt)ϖ7(t,Λt,Υtϵ,ωtϵ)]dt+E0^h~(t,Λt,Υtϵ,ωt)h~(t,Λt,Υtϵ,ωtϵ)dt.(123)

Proof: Using the Definition 2, the following can be obtained:

J(0,Υ0,ωtϵ)J(0,Υ0)+ϵ.(124)

Based on Lemma 4, a constant Γ=ϵ1ι2 and ω~tϵUad[0,^], so that the following are hold:

d(ω~tϵ,ωtϵ)ϵ1ι2,J(0,Υ0,ω~tϵ)J(0,Υ0,ωt)+ϵι2d(ω~tϵ,ωt).(125)

For practical purposes, we denote:

J~(0,Υ0,ωt)=J(0,Υ0,ωt)+ϵι2d(ω~tϵ,ωt),(126)

which means that:

J~(0,Υ0,ω~tϵ)J~(0,Υ0,ωt).(127)

It is straightforward to demonstrate that ω~tϵ serves as the perfect adjustment for the operator J~(0,Υ0,ωt). For each interval [t,t¯+δ][0,^], where t¯[0,^), we state

ωtδ=ω~tϵ1t[0,^][t,t¯+δ]+ωt1t[t,t¯+δ],ωt,ω~tϵUad[0,^],(128)

then, we can fix that ωtδUad[0,^]. Due to ω~tϵ being optimal control for J~(0,Υ0,ωt), then:

J~(0,Υ0,ω~tϵ)J~(0,Υ0,ωtδ).(129)

It implies that

J~(0,Υ0,ω~tϵ)J(0,Υ0,ωtδ)+ϵι2d(ωtδ,ω~tϵ).(130)

Considering the concept of the control process ωtδ and the metric d, we have:

d(ωtδ,ω~tϵ)=G~{(t,ϖ9)[0,^]×Ω:ωδ(t,ϖ9)ω~ϵ(t,ϖ9)}δ,(131)

J(0,Υ0,ωtδ)J~(0,Υ0,ω~tδ)ϵιd(ωtδ,ω~tδ)ϵιδ.(132)

It follows that

J(0,Υ0,ωtδ)J~(0,Υ0,ω~tδ)=E0^[h~(t,Λt,Υtδ,ωtδ)h~(t,Λt,Υ~^ϵ,ω~tδ)]dt+h^(Λ^,Υtδ)h^(Λ^,Υ~^ϵ)E0^[h~(t,Λt,Υtδ,ωtδ)h~(t,Λt,Υ~^ϵ,ωtδ)]dt+Et¯t¯+δ[h~(t,Λt,Υ~^ϵ,ωtδ)h~(t,Λt,Υ~^ϵ,ω~tδ)]dt+h^Υ(Λ^,Υtδ)(ΥtδΥ~^ϵ).(133)

Moreover, we have

δϵιE0^[h~(t,Λt,Υtδ,ωtδ)h~(t,Λt,Υ~^ϵ,ωtδ)]dt+Et¯t¯+δ[h~(t,Λt,Υ~^ϵ,ωtδ)h~(t,Λt,Υ~^ϵ,ω~tδ)]dt+E0^HΥ(t,Λt,Υtδ,ωtδ,f11δ(t),f2δ(t),ϕδ(t,Ψ))(Υ~^ϵΥtδ)dt+E0^f11δ(t)[ϖ7(t,Λt,Υtδ,ωtδ)ϖ7(t,Λt,Υ~^ϵ,ω~tδ)]dt+E0^f2δ(t)[ξ(t,Λt,Υtδ,ωtδ)ξ(t,Λt,Υ~^ϵ,ω~tδ)]dt+E0^Yϕδ(t,Ψ)[g(t,Λt,Υtδ,ωtδ,Ψ)g(t,Λt,Υ~^ϵ,ω~tδ,Ψ)]q2(dΨ)dt.(134)

Consequently, we have

ϵιE[h~(t,Λt,Υ~^ϵ,ωt)h~(t,Λt,Υ~^ϵ,ω~tδ)]+E[f1~1ϵ(t)[ϖ7(t,Λt,Υ~^ϵ,ωt)ϖ7(t,Λt,Υ~^ϵ,ω~tδ)]]+EY[ϕ~ϵ(t,Ψ)[g(t,Λt,Υ~^ϵ,ωt,Ψ)g(t,Λt,Υ~^ϵ,ω~tδ,Ψ)]q2(dΨ)]+E[f2~ϵ(t)[ξ(t,Λt,Υ~^ϵ,ωt)ξ(t,Λt,Υ~^ϵ,ω~tδ)]].(135)

In view of Theorem 7 and the assertion (A1), we find

E{0^f1~1ϵ(t)f11ϵ(t)ρdt}1ρ×E{0^b(t,Λt,Υ~tϵ,ωt)b(t,Λt,Υ~tϵ,ω~tϵ)ρρ1dt}11ρC{d(ωtϵ,ω~tϵ)ρΨ2}1ρE{0^(1+Υ~tϵ+ωt+ω~tϵ)ρ(ρ1)dt}11ρC1d(ωtϵ,ω~tϵ)Ψ/2.(136)

On the same way, we can derive from assertion (A1) and applying Theorem 5 and 6, we have

E{0^f11ϵ(t)2dt}12E{0^b(t,Λt,Υ~tϵ,ωt)b(t,Λt,Υtϵ,ωt)2dt}12+E{0^f11ϵ(t)2dt}12E{0^b(t,Λt,Υtϵ,ω~tϵ)b(t,Λt,Υ~tϵ,ω~tϵ)2dt}12C2d(ωtϵ,ω~tϵ)Ψ/2(137)

and

E{0^f11ϵ(t)2dt}12E{0^b(t,Λt,Υtϵ,ωtϵ)b(t,Λt,Υtϵ,ω~tϵ)21ωtϵω~tϵdt}12C3{E{0^b(t,Λt,Υtϵ,ωtϵ)b(t,Λt,Υtϵ,ω~tϵ)4dt}12E{0^1ωtϵω~tϵdt}12}12C4E{0^(1+ωtϵ+Υtϵ+ω~tϵ)4dt}14E{0^1ωtϵω~tϵdt}14C5d(ωtϵ,ω~tϵ)1/4.(138)

So that, combining (136), (137) and (138), we get

E0^[f1~1ϵ(t)][b(t,Λt,Υ~tϵ,ωt)b(t,Λt,Υ~tϵ,ω~tϵ)]dtE0^[f11ϵ(t)][b(t,Λt,Υtϵ,ωt)b(t,Λt,Υtϵ,ωtϵ)]dtC6d(ωtϵ,ω~tϵ)Ψ/2+C5d(ωtϵ,ω~tϵ)1/4.(139)

Observe that d(ωtϵ,ω~tϵ)1 and define ι=min{12,Ψ}, which means that

E0^[f11~ϵ(t)][b(t,Λt,Υ~tϵ,ωt)b(t,Λt,Υ~tϵ,ω~tϵ)]dtE0^[f11ϵ(t)][b(t,Λt,Υtϵ,ωt)b(t,Λt,Υtϵ,ωtϵ)]dtC7d(ωtϵ,ω~tϵ)ι/2.(140)

This completes the proof.

5  Numerical Experiments

Numerical modeling of CHIKV transmission that incorporates latently infected individuals and Poisson random measures represents a sophisticated approach for understanding the stochastic dynamics of disease spread. In these frameworks, the Poisson random measure accounts for the random occurrence of events—such as sudden outbreaks or control interventions—that influence the dynamics of latent infections.

However, a prominent example is the comprehensive stochastic model developed for CHIKV transmission via Aedes albopictus, which effectively captures both outbreak patterns and suppression strategies. This model demonstrates broader applicability across various nations [1], as it integrates multiple factors including virus strain variation, vector control, and geographic containment measures. The inherent randomness of disease transmission is modeled by treating the number of daily human-vector interactions as a Poisson-distributed random variable. To improve computational efficiency, especially when the average interaction rate is high, a normal approximation is employed for simulating daily contacts.

By simulating the spatiotemporal progression of CHIKV, this approach yields valuable insights into the design and evaluation of intervention strategies. Overall, numerical modeling techniques that incorporate Poisson random measures and other stochastic elements serve as powerful tools for analyzing complex transmission patterns and optimizing control measures under uncertainty.

In order to outline the numerical approach and present the experimental results derived from the implementation of various assertions, a numerical scheme was developed to solve model (4), based on the classical numerical method described in [54]. To efficiently construct the algorithm, we introduced a set of integers, K=0,1,,k, where kZ and ξs. A uniform step size, Δt=TK, was utilized to discretize the time interval [0,], ensuring accuracy and consistency in the numerical analysis. Moreover, for ι{1,,6} and 𝒵Kk=S+L+I+V+B+Z, we define: 1Zin𝒲(tn+1)𝒲(tn)=1tκi,n, where the latter expression represents the standard Gaussian noise containing mean zero and standard deviation to be one. Furthermore, the impulsive noise with amplitude ω is computed when s(0,+) and ω(s) should be appropriately defined.

Sm+1=Sm+(πϖ1S(t)βS(t)V(t))Θt+σ1SmdB1,m(t)+σ122Sm(ΘB1,m2Θt)Θ1()SmΘm,Lm+1=Lm+((1ρ)βS(t)V(t)(Θ+φ)L(t))Θ(t)+σ2LmB2,m(t)+σ222Lm(ΘB2,m2Θt)Θ1()LmΘm,Im+1=Im+(ρβS(t)V(t)+φL(t)ϖ2I(t)ϵI(t)Z(t))Θ(t)+σ3ImB3,m(t)+σ322Im(ΘB3,m2Θt)Θ3()ImΘm,Vm+1=Vm+(ϖ3I(t)ϖ4V(t)ϖ5V(t)B(t))Θt+σ4BmB4,m(t)+σ422Bm(ΘB4,m2Θt)Θ4()BmΘm,Bm+1=Bm+(ϖ8Im+πBmϖ10hVm)Θt+σ5SmdB5,m(t)+σ522Vm(ΘB5,m2Θt)Θ5()VmΘm,Zm+1=Zm+(ϖ8+ϖ9I(t)Z(t)ϖ10Z(t))Θt+σ6ZmB6,m(t)+σ622Zm(ΘB6,m2Θt)Θ6()ZmΘm.(141)

To generate numerical results for the framework (3), the non-negative preserving truncated Euler-Maruyama (PTEM) technique [55] was employed in conjunction with the previously discussed strategies. The PTEM approach has been widely adopted by researchers for analyzing complex physical processes involving stochastic dynamics [56]. This method was selected for its simplicity and robustness in handling jumps induced by Poisson random measures.

For the model (4), specific parameter configurations were required to quantitatively validate the theoretical findings. Two distinct sets of input parameters, summarized in Section 5.1.2, were employed to simulate the system. Such parametric values also include the initial population sizes of individuals. For each parameter grouping, the framework was modeled over the timeframe [0,100], and the behavior of every component was comprehensively investigated via pictorial depictions.

5.1 Fitting CHIKV Data of Florida State, USA

Here, we use the average per month of CHIKV occurrences documented in Florida, USA, between April 2005 and December 2017 to figure out the unidentified characteristics and ICs of system (2). Inadvertently contaminated individuals are taken into consideration in this investigation. The threshold parameter, R0L, is also computed, along with its mean value and confidence interval.

5.1.1 Data Collection and Assessment

The Florida Department of Health [57] provided us with confirmed case information covering April 2005 and December 2017 to calibrate a mathematical framework describing the propagation evolution of CHIKV in Florida, USA. The total quantity of documented infections, prevalence rates, and demographic profiles by age and geography are among the many details about CHIKV occurrences documented during the virus’s inception that are included in this repository. The monthly occurrence of cases reported for every demographic is the primary purpose of this investigation. The overall incidence of CHIKV per 100,000 people in diverse generations from April 2005 and December 2017 is shown in Fig. 2a, which accounts for the contribution of inadvertent contracted infections to the evolution of propagation as

Prevalence of the  th demoghraphic=Proportion of freshly identified instances in the  th agecateogryThe general demographic of the  th age category×100,000.(142)

images

Figure 2: (a) Seasonal fluctuation in the prevalence of CHIKV in Florida, USA, across demographics of people per 100,000 people. Integrating an undetected infection phase inside host cells, the findings illustrate CHIKV characteristics. From early spring through summer, heightened predominance is regularly noted. With an overall mean of 84.2783 instances per 100,000 people, age-dependent average monthly prevalence figures are described, varying from 0.2851 (ages 0–5) to 14.8427 (ages 66+). For a complete quantitative decomposition, see Table 3. (b) Prevalence of CHIKV in Florida, USA, across demographics of people per 100,000 on a gender basis

Table 2 displays the aggregate population of Florida from 2005 to 2019, which was gathered according to the Florida Department of Economic and Demographic Research and the U.S. Census Bureau [58]. Fig. 2b displays the 2010 United States Census information for the state of Florida, which includes age and gender-specific demographic profiles.

images

The frequency of CHIKV per 100,000 people in every demographic varies seasonally, with notable elevations emerging from the beginning of spring to summertime every year, as seen in Fig. 2a. The general population’s estimated monthly CHIKV incidence is 84.2783 cases per 100,000 people. The data shown are age-dependent average recurrence values: 0.2851 for ages 0–5, 0.3288 for ages 6–10, 0.7130 for 11–15, 4.8932 for 16–20, 6.5233 for 21–25, 6.5874 for 26–30, 5.7410 for 31–35, 4.9694 for 36–40, 5.2128 for 41–45, 5.9061 for 46–50, 8.4524 for 51–55, 8.1967 for 56–60, 11.6263 for those 61–65, and 14.8427 for those aged 66 and older (see Table 3). These patterns correspond to the behavior of CHIKV when the host has a latently contaminated lymphocyte component.

images

The age group under fifteen years old has the lowest frequency of CHIKV, while those over 65 had an elevated incidence per 100,000 people. Furthermore, as illustrated in Fig. 3, Pearson’s correlation assessment demonstrated a substantial positive association between the demographic variability of CHIKV contaminated people from 2005 to 2017 and the overall incidence of CHIKV per 100,000 individuals. In particular, the correlation coefficient between the mean age of CHIKV-infected people and the occurrence of CHIKV per 100,000 people was higher than 0.85 (p<0.01) over this time frame, indicating that older people are more susceptible to contracting the CHIKV.

images images

Figure 3: Correlation between age-dependent variations and the prevalence of CHIKV across demographics in Florida, USA, per 100,000 individuals from 2005 to 2017. The prevalence consistently peaks from early spring through summer, with the analysis emphasizing age-specific monthly prevalence, spanning from ages 0–5 to 66 and older

5.1.2 Model Validation and Population Stratification for CHIKV

By analyzing the outcomes of the proposed CHIKV transmission model—which incorporates latently infected cells—against the actual number of confirmed and potential cases, the model’s feasibility is validated. This framework simulates the proportion of potentially acquired CHIKV infections in the state of Florida, USA (see [57]). To ensure realistic and comprehensive simulations, the general population is stratified into 14 age groups, ranging from 0–5 years to 66 years and above. This age-structured approach captures heterogeneous susceptibility, contact patterns, and immune responses across different age cohorts, which is particularly relevant for arboviral infections like CHIKV. Subsequently, all parameters and ICs for the system of ODEs (2) governing CHIKV dynamics are estimated. These estimations incorporate both the demographic characteristics of the population and the host immune response, including the latent phase of cellular infection.

(I)   To represent demographic behavior, the general population’s birth rate, denoted by π, is categorized by chronological age and incorporated into the framework. Data-driven obtained from the Florida U.S. Census Bureau [58], it is estimated that individuals under the age of 15 and over the age of 50 contribute minimally to the overall fertility rate. Consequently, the fertility rates for these age groups are set to zero. The nonzero fertility rates are estimated as follows: π1=0.92×103, π2=5.57×103, and π3=6.65×103.

(II)   A typical lifespan in the USA is approximately 76 years, data-driven from the U.S. Census Bureau [58]. Accordingly, natural mortality rates (ϖ1k1) are calculated on a monthly basis. For example, for individuals with an average lifespan of 76 years, the monthly natural death rate is given by ϖ11=176×12. Similarly, if a particular demographic group has an average lifespan of 71 years or 66 years, the corresponding monthly natural death rates are ϖ12=171×12 and ϖ13=166×12, respectively. These age-specific mortality rates, ϖ1k1, are incorporated into the simulation to accurately reflect generational attrition across different demographic segments.

(III)   According to epidemiological research [59], over 10% of individuals who come into contact with CHIKV and harbor a latent cellular infection eventually develop symptoms during their lifetime. Furthermore, it is estimated that within the first two years after infection, approximately 50% of these symptomatic cases—representing about 5% of all infections—progress to a persistent illness [60]. Consequently, we assume a uniform early progression probability across all age groups and set β=0.4 for 114.

(IV)   Let ρ denote the proportion of host cells that are productively infected. The fraction of individuals in age group who acquire immunity rather than contracting CHIKV upon exposure is represented by 1ρ. According to clinical studies, the effectiveness of the CHIKV vaccine persists for approximately 10 years [61]. Therefore, we assume that significant immunization occurs only within the 0–10 year age range (groups =1,2,3), and we set:

1ρ={0.95[1,3]0[4,14].(143)

Thus, vaccination reduces vulnerability to successful infection (i.e., development to nonzero ρ) by 95% in the youngest two age categories, but no vaccine-derived immunity is anticipated after age 10.

(V)   Here, Θ represents the per-cell death probability for cells persistently infected with CHIKV. Exogenous transmission may occur in individuals with latent infections at a rate proportional to Θ. The probability of infection for individuals in age group is denoted by , where for 114. Since persistent infection confers partial protection against reinfection, it follows that 0<Θ<1. Based on the estimates provided in [60], we assume a comparable level of immunity across all age groups, with Θ[0.15,0.25] for =1,,14. While π modifies the susceptibility of latently infected individuals to subsequent infection, Θ governs the decay rate of the latent compartment in the model formulations.

(VI)   The rate at which subconsciously contaminated cells become productively infectious cells is represented by φ. Since they only have partial immunity, recovered people can get contaminated again at the rate φ (114). Their amount of immunity is thus defined as δ, with 0φ1. We assume a uniform shielding level for any demographic as φ[0.05,0.25], =1,,14 taking into account the assumptions of [59]. While records the receptivity of treated hosts to another infection, φ controls the passage from the latent category into an acute infection.

(VII)   The ϵ is the monthly rate at which CHIKV-latently infected cells reactivate into productive infection in age group . Based on the age-specific reactivation risks estimated by [62], we have converted their lifetime probabilities into equivalent monthly rates. Thus, the reactivation parameters are given by:

ϵ={[8.33×106,1.67×105],[1,3],[1.50×105,2.33×105],[4,10],[1.67×105,1.60×104],[11,13],[1.67×105,3.01×104],=14.(144)

The monthly likelihood that a CHIKV-latent cellular resource could come back into an active infection in all age categories is represented by such ϵ levels.

(VIII)   We represent by ϖ2 the age-dependent likelihood that a vulnerable member of cohort contracts the virus after coming into touch a potential contagious host, in addition to ϖ2 a the per-cell mortality rate of CHIKV-infected cells, which controls the viral transmission period. For the majority of infectious agents influence indirect estimation of ϖ2 is typically not possible [4]. Additionally, while large-scale dissemination research (such as in biological representations) can provide insight into the mechanisms of dissemination, they are frequently unsuitable for infectious viruses owing to logistical and righteous limitations ([5]).

We used continuously Morlet wavelet estimation ([63]) to analyze the monthly incidence of cases newly identified in all age categories in order to demonstrate the clear periodicity in CHIKV prevalence. Throughout all 14 communities, the wavelet strength spectrum showed an impressive yearly pattern that was substantial at the 5% level (see Fig. 4a,b). Therefore, we describe ϖ2 as an oscillating function that reflects this annual fluctuation, and the cell-death component ϖ2 an establishes the duration of infectiousness once lymphocytes acquire effectively infested as ϖ2(t1)=ϖ2~(1+ϖ2¯sin(π/6+ϕ~)), where ϕ~ is the periodicity of the T-periodic function, ϖ2¯ is the intensity of seasonally fluctuations or alternatively the extent of cyclical nature, and ϖ2~ is the foundation degree of propagation.

(IX)   The total number of people across various age groups is represented as N, as shown in Table 4, according to data collected in the 2010 demographic surveys released by the Centers for Disease Control and Prevention (CDC), USA [64]. Based on recent projections, approximately 350 million people in the USA have been affected by CHIKV. Therefore, the initial proportion of people with latent infections is calculated as follows:

L(0)=300,000,000×N=114N,114.

images images

Figure 4: The wavelet method was applied to analyze the spatiotemporal patterns of monthly new CHIKV cases in Florida, USA, across various age groups from April 2005 to December 2017. The first column displays the corresponding 95% confidence curve (green curve) and the average wavelet spectrum (red line). Additionally, the wavelet spectrum analysis of the monthly reported CHIKV cases time series is presented, with low power values depicted in cyan and blue, intermediate power in orange and yellow, and high power in red. The green line represents the 95% C-I

images

The initial values for the number of infected individuals I(0), virus concentration V(0), pathogen concentration B(0), and immune factor Z(0) are determined by fitting to available epidemiological data. Since adult vaccination programs against CHIKV are currently unavailable or not widely implemented, we assume that V(0)=0 for 34.

According to center of disease control and prevention [64], 90% of newly detected CHIKV cases receive medical treatment. Therefore, the initial number of treated individuals is assumed to be Z(0)=0.90×I(0), for 114.

The initial susceptible population is calculated by subtracting the number of virus concentration, latent, infected, pathogen concentrated, and immune factor from the total population in each age group:

S(0)=N(0)L(0)I(0)V(0)B(0)Z(0), (114).(145)

The CHIKV transmission framework with latent infectious cells has been validated through 800,000 repetitions using the MCMC methodology [65], with a burn-in period of 750,000 iterations. We use the recorded monthly prevalence of CHIKV cases as experimental input, considering epidemiological data specific to Florida, USA. These data sets are comparable to those typically used in host-vector interaction studies or more general viral infection modeling approaches. The MCMC procedure captures latent patterns and provides a probabilistic understanding of how well the model fits the observed data, enabling the estimation of unknown parameter values and ICs:

λ^=(λ^1,,λ^ϖ2,,λ^B),(146)

where

λ^={(ϖ3,ϖ4,ϖ5,ϖ6,ϖ7,ϖ8,ϖ9,ϖ10,δ,I(0),V(0),B(0)),[1,2](ϖ3,ϖ4,ϖ5,ϖ6,ϖ7,ϖ8,ϖ9,ϖ10,δ,Z(0)),[3,12].(147)

Let C~(t,λ^), where 112, denote the total number of CHIKV-infected individuals (including latently infected) in the th age category. Accordingly, the entire community in the th category, stratified by infection status—including susceptible, latently infected, virus concentration, and immune factors—can be articulated as:

dC~(t,λ^)dt=ϖ4ϖ3I,(1B).(148)

Assume that the overall cumulative of infectious people in the th category can be presented as:

P~(t,λ^)=ϖ4ϖ3I,(1B).(149)

where P~(t,λ^) represents the number of new prey individuals (or prey biomass) of the th age group entering the predator-prey interaction, and simulations progress in increments of one month. By collecting ς~ autonomous sample data from the th demographic, demonstrating the novel prey species or prey biomass observed at the ζth month. The framework was trained using statistics from 2006 to 2015, then it was tested and validated using the dataset from 2016. It is possible to communicate newly collected observational evidence as G(t)=(G1(t),G2(t),,GB(t)), where G indicates a ς~×B matrix. In this case, G stands for the measured biomass or population counts over time for the various ages of the predator and prey species. Suppose a rectangular matrix ε~ with ς~×B follows a matrix-variate probability density function, that is, ε~N~(0,Iς~,) [66]. Consequently, the following is an expression for the data G:

G=Q+ε~,ε~N~(0,Iς~,),(150)

where Q represents a ς~×B matrix and Q indicates the numerical outcomes of over all CHIKV cases of model (2), i.e., Q=(Q~1(t,λ^),Q~2(t,λ^),,Q~B(t,λ^)). For convenience, we suppose that during the task, =diag(β~1,,β~B). Assumed to be an autonomous Gaussian prior characterization is the unidentified component λ^ of model (2). Thus, we get

λ^kN~(Ψ~k,φ~k2),k=1,,~,(151)

where ~ represents the quantity of unidentified factors. Additionally, we suppose that the error variance’s inverse has a gamma distribution, as formerly stated, having a particular form

β~ζ2Γ(B02,B0𝒮022),ζ=1,2,,B,(152)

where B0 and β~𝒮02 represent the prior mean and precision of variance β~ζ2, respectively.

Applying a Gaussian deviation approach, the likelihood function G(G|λ^,) for ς~ autonomous and uniformly dispersed data using (150) is

G(G|λ^,)=(2π)ς~B/2||ς~/2exp{trace(1SS(δ^)2)},(153)

where SS(λ^)=(GQ)T(GQ). For ζ=1,2,,B, the joint probability distribution of β~ζ2 yields

G(β~12,,β~B2|G,λ^)G(G|β~12,,β~B2,λ^)G(β~12,,β~B2)=G(G|β~12,,β~B2,λ^)ζ=1BG(β~ζ2)=(2π)ς~B/2||ς~/2exp{trace(1SS(δ^)2)}ζ=1B(B0𝒮022)B02Γ(B02)(β~ζ2)B021exp(B0𝒮022β~ζ2)=(2π)ς~B/2||ς~/2exp{trace(1SS(δ^)2)}ζ=1B(B0𝒮022)B02Γ(B02)||B021exp(1B0𝒮022)||ς~2B021exp{trace(1SS(δ^)2)+trac(1B0𝒮022)}.(154)

The subsequent expression allows for the computation of the prior sum of squares for the supplied components λ^ provided, we consider independent Gaussian prior characterization for them:

SSprior(λ^)=k=1~(λ^kΨ~kφ~k)2.(155)

It is then possible to describe the posterior distribution of factors λ^ in the following manner assuming a specific quantity of dispersion β~ζ, (ζ=1,2,,B):

G(λ^|G,)G(G|λ^,)G(λ^1)G(λ^2)G(λ^~)=G(G|λ^,)ζ=1BG(λ^ζ)=(2π)ς~B/2||ς~/2exp{trace(1SS(δ^)2)}k=1~12πφ~kexp{12(λ^kΨ~kφ~k)2}=(2π)ς~B/2||ς~/2exp{trace(1SS(δ^)2)}k=1~(12π)~1φ~1φ~2φ~~exp{12k=1~(λ^kΨ~kφ~k)2}exp{12(trace(1SS(λ^))+SSprior(λ^))}.(156)

The following is a possible expression for the probabilistic ratio required in the Metropolis–Hastings acceptability likelihood:

G(λ^1|G,)G(λ^2|G,)=exp{12(1SS(λ^2)1SS(λ^1))+12(SSprior(λ^2)SSprior(λ^1))},(157)

where the outcome of creating an additional characteristic set is represented by λ^2 and the quantity of the existing characteristic set is represented by λ^1. Consequently, there is a possibility that the recently introduced unidentified factor value λ^2 will ultimately be approved as

min{1,G(λ^1|G,)I(λ^2|G,)}.(158)

Unidentified characteristics’ prior understanding is provided by

ϖ3[0.05,0.95],ϖ4[5.5,9.5],ϖ5[0.45,1.05],ϖ6[0.12,0.68],112,ϖ7[0.25,0.65],ϖ8[0.9,2.2],ϖ9[0.015,0.12],ϖ10[1.4,2.1],112,δ3[1.8,5.2],I(0)[1×105,2.5×104],12,V(0)[5×105,1.1×103],B(0)[3.5×108,2.8×107],Z(0)[3.8×108,2.9×107],112β~[0.0001,0.0002],λ^[0.005,0.010],13,β~[0.00018,0.00028],λ^[0.005,0.007],49,β~[0.00020,0.00193],λ^[0.005,0.016],911,β~[0.00020,0.00365],λ^[0.005,0.025],=12,(159)

and a multivariate normal distribution describes the suggested concentration.

Based on epidemiological field data collected in Florida, USA, and as shown in Fig. 5, we fitted the CHIKV model (2)—which incorporates latency and symptomatic stages of infection—using population-level incidence data stratified by age and infection status. This dataset represents the monthly density of infected individuals (per 100,000 population) across structured compartments, including exposed (latently infected), symptomatic, and immune factor cases. The model was calibrated using the MCMC approach, with the final 10% of 50,000 posterior samples employed for statistical inference and parameter estimation.

images

Figure 5: The monthly CHIKV incidence per 100,000 people for various age-factors from April 2005 to December 2017 is shown in the fitting findings. When model (2) is fitted to the measured time series, the simulated trajectories are shown by the solid red lines. The first 120 months of training data are represented by black circles, while the latter 36 months of testing data are represented by green circles. Whereas the light blue shaded area displays the 95% prediction interval (P-I), the magenta shaded area indicates the 95% C-I. A random 10% selection of the previous 50,000 posterior samples was used to generate the final distribution after parameters were inferred using MCMC

Fig. 5 presents the fitted results across age-stratified population classes, showing close agreement between the observed incidence data and the simulated infected population densities. Surface plots for key parameters and ICs of model (2) were generated through MCMC sampling and are displayed in Fig. 6. The constructed model framework demonstrates robust predictive capabilities under the influence of viral transmission dynamics, including latent progression and symptom development. The ratio of our sample size to the free parameters of the model is 28.8:1 > 10:1 [67].

images

Figure 6: Three-dimensional plot of the predicted outcomes of monthly CHIKV transmission per 100,000 people from April 2005 to December 2017 for various demographic variations. The surface represents the simulated CHIKV prevalence generated from model (2), while black circles correspond to the reported data for each age group over time. CHIKV commonly presents with symptoms such as high fever, severe joint pain, rash, headache, and fatigue, which may vary in severity across different age groups

5.1.3 Contact Matrix for CHIKV Model

Let f2¯ denote the initial contact matrix, shown in Table 4, containing components f2¯ιζ (ι,ζ=1,2,,c), where c constitutes the demographic categories in the initial matrix, and ι and ζ index the rows and columns, respectively. An adjusted contact matrix S=(Zκ), with κ,=1,2,,r, is constructed, where r represents the overall demographic categories within simplified framework. Each extended demographic group v¯ aggregates a subset of the original groups, namely from ι=l1(κ) to ζ(κ). The frequency of contact between individuals in age categories ι and ζ is then provided by:

V¯ι=ζ=l1()v¯()f2¯ιζ.(160)

Using Table 4 as a reference, let Nι denote the population size within age group ι. Based on this information, we calculate the interaction rate between age categories κ and by computing the population-weighted mean of each component, denoted by V¯. To address interactions between different generations (i.e., off-diagonal components), we determine the overall interactions from κ to and from to κ. Consequently, the total number of interactions between categories κ and can be written as:

L¯κ=ι=l1(κ)v¯(κ)NιV¯ι,L¯κ=ι=l1()v¯()NιW¯ικ(161)

To ensure symmetry between L¯κ and L¯κ, we take their average, that is,

Wκ=Wκ=L¯κ+L¯κ2.(162)

In general, the updated contact matrix constituent can be depicted in the form of:

sκ=Wκι=l1(κ)v¯(κ)Nι,sκ=Wκι=l1()v¯()Nι.(163)

In this case, sκ represents the monthly interaction rate between a person in the age category κ and others in age grouping . The diagonal’s overall interaction rate is represented by:

sκκ=ι=l1(κ)v¯(κ)NιV¯ιι=l1(κ)v¯(κ)Nι.(164)

The contact matrix is essential for studying infections such as CHIKV in epidemic modeling, as it quantifies interactions among different age groups. It captures the frequency of interaction involving susceptible people (columns) and infectious people (rows) across various age categories. Understanding these interactions aids in forecasting disease transmission processes, which are influenced by factors such as community behavior and transportation patterns. The matrix, which can be constructed from demographic data, illustrates how different age groups connect—for example, children interacting more frequently with their families (see Fig. 7). It serves a vital function in designing targeted interventions to curb disease spread, like immunization drives or social distancing strategies. Overall, the contact matrix offers vital insights into epidemic dynamics and helps inform effective public health strategies.

images

Figure 7: The contact matrix in demographic-structured outbreak models for the propagation of the CHIKV model (2) illustrates how different generations collaborate to forecast transmission and guide focused preventative measures

6  Results and Discussion

To analyze the stochastic framework and validate the parameterized model, we conduct numerical simulations of our model (4) in the following section. The objective is to evaluate the effectiveness of coordinated CHIKV prevention and control strategies.

6.1 Sensitivity Analysis

In what follows, the basic reproduction number, R0I, for the CHIKV model (4) is determined based on the predicted feature estimates and is found to be approximately 1.4978 (95% C-I: 1.4968–1.5823), as illustrated in Fig. 8a,b, respectively. The framework demonstrates consistent robustness since R0I>1, indicating that CHIKV will not go extinct in future generations in the absence of additional control measures. This persistent nature suggests that, even with the current control mechanisms, the infection has the potential to continue spreading within the community.

images

Figure 8: Estimation and distribution of the threshold parameter R0I for the demographic variability CHIKV system. (a) displays the scatter of R0I values generated from posterior predictive samples. Blue dots represent values within the 95% C-I, red pluses represent values outside the C-I, and horizontal red dashed lines mark the C-I bounds at (1.4968, 1.5823). The estimated mean of R0I is approximately 1.4978. (b) illustrates the frequency distribution of R0I, with a red curve representing its fitted probability density function. Since R0I>1, the model suggests a sustained potential for CHIKV transmission in the absence of additional interventions. These results highlight the robustness of the modeling framework and support further global sensitivity analysis to identify influential parameters across age groups

Subsequently, we assess the broad dispersion and comparative responsiveness of the parameters incorporated in the CHIKV framework using Latin Hypercube Sampling (LHS) and Partial Rank Correlation Coefficients (PRCCs) (McKay et al. [68]). The aim is to identify the key factors influencing the progression of CHIKV infection. The considered criteria include: β~[0.0001,0.0002], λ^[0.005,0.010],13,β~[0.00018,0.00028], λ^[0.005,0.007], 49, β~[0.00020,0.00193], λ^[0.005,0.016], 911, β~[0.00020,0.00365], λ^[0.005,0.025], =12. The output field represents the yearly number of newly identified CHIKV cases, and a value for ϖ is provided for 314. It is assumed that all supplied parameters follow a normal distribution. Table 5 lists the dispersion values for β~ and λ^. The coefficients of dispersion for ϖ are set to 0.2 and 0.02, respectively.

images

Table 5 presents the sensitivity factors ϖ1, ϖ4,ϖ5,ϖ8 and ϖ10 in relation to new cases of CHIKV in 2017, specifically using an age-structured model. The results indicate the recurrence rate for recuperated people aged 16 and above (i.e., λ for [4,14]) shows a strong positive correlation with the total number of new cases. In contrast, the re-occurrence rate for previously treated people younger than 16 (that is, λ for [1,3]) does not exhibit a significant correlation including more incidence, highlighting the importance of preventing relapse in persons above 16 years old.

Further analysis reveals that the risk of reinfection in people harboring latent virus (i.e., λ for [4,14]) aged beyond 16 years is more significant compared to those under 16 years (i.e., λ for [1,3]). Additionally, the CHIKV diagnosis rate (i.e., ρ for [1,14]) is negatively and strongly associated for new incidence, suggesting that improving therapeutic strategies to reduce diagnostic delays can substantially lower the incidence of CHIKV.

Lastly, β is the rate of transmission from S to V due to CHIVK (i.e., β for [4,14]) aged over 16 years is significant unfavorable relationship between the aggregate amount of instances rising. Notably, the highly negative association was observed between the overall of reported instances and the regular immunization levels of at-risk people above 66 years old, compared to those aged 20 to 26, underlining the effectiveness of targeted vaccination efforts.

6.2 Extinction of Model

To comprehensively examine the critical factors contributing to the extinction of the CHIKV (4) in human populations—as well as those facilitating its long-term persistence—we refer to the threshold condition R0I<1. This condition represents a biologically significant tipping point, below which the basic reproduction number indicates a sustained decline in infection incidence over time. Theorem 3 was specifically proven under this constraint, providing a rigorous theoretical foundation for the guaranteed eradication of CHIKV with probability one, assuming essential biological and intervention-based criteria are met.

In this context, virus extinction is primarily driven by stochastic perturbations, natural recovery processes, depletion of infectious reservoirs, increased vector mortality, and the implementation of targeted public health interventions. These include vector control strategies, personal prophylactic measures, and improved environmental hygiene. Even in scenarios with an initially high infection burden, these mechanisms act synergistically to disrupt sustained transmission, ultimately leading to the disappearance of the virus from the host population.

To quantitatively analyze and visualize these findings, we developed a stochastic modeling framework based on Example 1, incorporating random fluctuations to account for real-world uncertainty. Fig. 9 presents numerical simulations illustrating the model’s dynamic progression toward the disease-free equilibrium, consistent with the behavior predicted by the corresponding deterministic system. The resulting stochastic trajectories visibly converge toward the extinction boundary, reinforcing both the biological plausibility of CHIKV eradication under coordinated control efforts and the predictive validity of the proposed framework.

images

Figure 9: Comparative simulation outcomes of the CHIKV model under deterministic (2), white noise (3), and Lévy noise (4) influences, using the initial parameter values as Test 1 defined in Section 5.1.2. Each subplot depicts the temporal evolution of a distinct compartment—(S(0),L(0),I(0),V(0),B(0),Z(0)) = (0.95, 0.57, 0.6, 0.5, 0.25, 0.15) demonstrating convergence to the disease-free equilibrium. This behavior aligns with the theoretical prediction given by Theorem 3, as the basic reproduction number R0I=0.178<1, indicating stochastic extinction and long-term eradication of the infection

Example 1: In this scenario, the initial parameter values used for Tests 1, 2, and 3 are presented in Section 5.1.2. These values specify the initial conditions for the susceptible, latent, infectious, vector, and two additional compartments, respectively, reflecting a realistic epidemiological setting. Based on these outcomes, we calculate the appropriate threshold factor R0I=0.178. This value satisfies the crucial criterion outlined in Theorem 3, which states that a virus cannot persist in the community for an extended period if R0I<1. Since R0I is smaller than unity, the condition is met. According to the scientific principles of stochastic extinction, this implies that the infection will almost surely disappear over time. Consequently, under this restriction regime, the requirements for CHIKV eradication are fulfilled. As a result, the model’s solution pathways asymptotically converge to the disease-free equilibrium. The following formulas describe how each individual component of the framework, representing different demographic categories, converges in probability to its corresponding disease-free state and exhibits asymptotic disintegration behavior:

limtsuplogL(t)t0,limtsuplogI(t)t0.

Fig. 9 provides statistical evidence for the gradual eradication of the virus in the general population, as confirmed by these changes. Identical behavioral modeling supporting the extinction outcomes, which are considered reliable, is shown in Fig. 10. This situation exemplifies stochastic extinction, where every solution pathway ultimately leads to the complete elimination of the virus. Notably, this convergence trend remains robust under both stochastic and deterministic influences. Furthermore, the impact of stochastic perturbations on disease progression is highlighted by the faster extinction rates observed in trajectories driven by Poisson random measure noise compared to those influenced by normal jump processes (see Fig. 11).

images

Figure 10: Comparative simulation outcomes of the CHIKV model under deterministic (2), white noise (3), and Lévy noise (4) influences, using the initial parameter values as Test 2 defined in Section 5.1.2. Each subplot depicts the temporal evolution of a distinct compartment—(S(0),L(0),I(0),V(0),B(0),Z(0)) = (0.85, 0.67, 0.5, 0.4, 0.3, 0.2) demonstrating convergence to the disease-free equilibrium. This behavior aligns with the theoretical prediction given by Theorem 3, as the basic reproduction number R0I=0.256<1, indicating stochastic extinction and long-term eradication of the infection

images

Figure 11: Comparative simulation outcomes of the CHIKV model under deterministic (2), white noise (3), and Lévy noise (4) influences, using the initial parameter values as Test 3 defined in Section 5.1.2. Each subplot depicts the temporal evolution of a distinct compartment—(S(0),L(0),I(0),V(0),B(0),Z(0)) = (1.95, 1.57, 1.6, 1.5, 1.25, 1.15) demonstrating convergence to the disease-free equilibrium. This behavior aligns with the theoretical prediction given by Theorem 3, as the basic reproduction number R0I=0.732<1, indicating stochastic extinction and long-term eradication of the infection

6.3 Mean Persistence Based Simulation

Focusing on persistence, this investigation evaluates the robustness of a hypothesis concerning CHIKV patterns within a population. Theorem 4 provides the theoretical foundation for understanding the virus’s transmission dynamics, and the results must satisfy its requirements. Section 5.1.2 in Test 2 addresses the case where R0I>1. Outcomes from deterministic, stochastic, and Lévy-based models are presented in Fig. 12, incorporating elements such as transmission unpredictability and Poisson random measures to demonstrate how stochastic factors influence disease prevalence. These methods account for random processes like migration, birth-death cycles, and the spread of infection. The analysis of epidemic duration, regional impacts, and the effectiveness of control interventions is enhanced through the concept of mean persistence. The deterministic perspective offers insights into population-level consequences and pathogen decline. This approach is crucial for identifying high-risk areas and facilitating targeted interventions such as travel restrictions and the strategic allocation of health resources.

images

Figure 12: Comparative dynamics of CHIKV transmission under deterministic (2), white noise (3), and Lévy noise (4) frameworks for the case R0L>1, as discussed in Section 5.1.2. These simulations, corresponding to Theorem 4, explore the persistence and variability of infection patterns in a population. Stochastic influences such as migration, demographic fluctuations, and transmission irregularities are incorporated to reflect real-world uncertainties. The figure highlights how random perturbations affect epidemic persistence, duration, and control strategies, aiding in the identification of high-risk zones and optimization of intervention planning

6.4 Impact of Actively Infected Cells in Concentration (φ)

The concentration of actively infected cells, represented by φ, is pivotal in shaping the dynamics of CHIKV transmission, influencing the system’s stability and the infection’s spread. Simulations show that reducing φ accelerates CHIKV eradication, emphasizing its importance in disease control. Nonlinear stochastic disturbances, such as Poisson random measures, capture the unpredictable spikes in infection rates caused by external factors like school closures or outbreaks in high-risk settings. These disturbances demonstrate that controlling CHIKV requires more than monitoring the basic reproduction number. CHIKV is regulated by adaptive immunity, and the effectiveness of monoclonal antibody treatments varies (see Fig. 13). The presence of these disturbances highlights the need to consider external, nonlinear factors in outbreak control. Ultimately, φ determines the intensity and spread of the infection, with higher concentrations leading to more widespread outbreaks. Lowering φ facilitates quicker containment. Understanding φ and incorporating stochastic variability into predictive models is key to effectively managing CHIKV transmission.

images

Figure 13: Influence of varying concentrations of actively infected cells φ on the spread and eradication of CHIKV model for deterministic (2), white noise (3) and Lévy noise (4) within a population. Reductions in φ=[0.15,0.45,0.75,0.85,0.95] accelerate the elimination of the infection, emphasizing the importance of controlling infected cell concentrations for effective disease management. The model incorporates nonlinear stochastic disturbances, such as Poisson random measures, to capture unexpected changes in infection rates caused by events like school closures, seasonal fluctuations, and incidents in high-risk settings. These disturbances highlight the need for models that account for external, non-linear factors that influence the transmission of CHIKV

6.5 Impact of ϵ on CHIKV Killing Rate Due to CTL Cells Immune Response

Moreover, the effectiveness of ϵ, representing the cytotoxic T lymphocyte (CTL) cells’ immune response, is pivotal in clearing infected cells and, consequently, influencing the CHIKV killing rate. It plays a crucial role in modulating the efficiency of immune responses by controlling how rapidly the immune system targets and eliminates infected cells. As ϵ increases, the immune system’s ability to eliminate infected cells improves, leading to a higher viral killing rate and more effective infection control. A higher value of ϵ results in a more aggressive immune response, which accelerates the clearance of virus-infected cells. This enhanced immune activity reduces the overall virus load, V(t), and contributes to a more rapid decline the infectious people, I(t). As the viral concentration decreases, transmission dynamics are directly affected, resulting in faster infection resolution and a reduced burden on the system. Conversely, a lower value of ϵ weakens the immune response, allowing the virus to persist longer and prolonging the infection’s duration, leading to a more severe and sustained epidemic. Simulations indicate that increasing ϵ significantly enhances immune effectiveness, thereby accelerating the elimination of infected individuals and reducing overall epidemic severity. This reinforces the importance of of immune efficiency in controlling the progression and impact of CHIKV outbreaks, emphasizing the significance of the immune response parameters in epidemic management. The dynamic behavior of this process illustrates how adjustments to ϵ can either mitigate or exacerbate the spread of the infection, particularly regarding the hypertrophic effects of CHIKV (see Fig. 14).

images

Figure 14: Effectiveness of the CTL cells’ immune response, influence the CHIKV killing rate. A higher ϵ accelerates the clearance of infected cells, reduces virus concentration, and leads to a more rapid decline in infected individuals, thereby mitigating the severity and duration of the epidemic. Conversely, a lower ϵ results in a less efficient immune response, prolonging infection and increasing epidemic severity. The figure illustrates the dynamic impact of immune response efficiency on the progression and control of CHIKV outbreaks

6.6 Near Optimal Control Analysis

A stochastic optimal control approach offers a powerful framework for analyzing the dynamics of CHIKV (52) propagation under the influence of continuous control interventions. This method effectively captures the inherent randomness in disease transmission, which may arise from environmental fluctuations, sudden demographic shifts, or unforeseen outbreaks. To accurately represent such stochastic variability, Poisson random measures are employed. These allow the modeling of discrete jump events within the system, reflecting abrupt and irregular changes such as localized infestations or sudden increases in vector populations [50].

The CHIKV model (52) is typically formulated using a compartmental structure that includes the susceptible, latent, and infectious human populations, along with virus concentration, pathogenic load, and immune response compartments. To represent various intervention strategies, a set of time-dependent control functions is introduced, denoted as u(t)=(u1(t),u2(t),u3(t)). Specifically, u1(t) corresponds to vaccination efforts, u2(t) captures public health initiatives aimed at reducing exposure through behavioral change and awareness campaigns, and u3(t) models vector control measures, such as habitat elimination and insecticide application.

SDEs with jump terms are used to illustrate the system. A Poisson random measure, which introduces unpredictability through discrete, occasional events, governs these jumps. Mathematically, both continuous fluctuations (represented by Brownian motion) and sudden shifts (represented by jumps) affect the evolution of a state variable, such as the pathogenic population I(t). This leads to the following behavior:

dI(t)=ϝ1(I(t),u(t))dt+σ3I(t)dB3(t)+ΦΘ3(Ψ)I(t)¯(dt,dΨ).(165)

The deterministic component of the dynamics is represented by ϝ1, the diffusion coefficient for stochastic noise is σ3, and the jump tendency is captured by the integral component in connection to the compensated Poisson random measure ¯(dt,dΨ). The system condition and random parameter Ψ, which could indicate the severity of an outbreak occurrence, are employed by the function Θ3 to calculate the size of the jumps.

The goal of the control approach is to achieve equilibrium between the economic cost of treatments and the impact of illnesses by minimizing a cost functional over a finite time horizon T. Usually, this is presented as

minu(t)E[0T(𝒞SS(t)+𝒞LL(t)+𝒞II(t)+D1u12(t)+D2u22(t)+D3u32(t))dt].(166)

The weights 𝒞S, 𝒞L, and 𝒞I represent the relative importance of reducing transmission, administering treatments, and controlling mosquito populations, respectively, while D1, D2, and D3 penalize the implementation of control measures.

Exact control is often unattainable due to the challenges posed by randomness and jumps. As a result, computational techniques such as adaptive programming, Pontryagin’s Maximum Principle in stochastic environments [69], or reinforcement learning-inspired approaches are employed to identify near-optimal control strategies. These methods allow for the dynamic adaptation of control strategies to prevent CHIKV spread, responding to observable situations and jump events.

The following is a detailed algorithm for implementing near-optimal control of the CHIKV epidemic model, governed by a SDE with Poisson random measures. This algorithm utilizes stochastic simulation with control approximation, often through the stochastic maximum principle or dynamic programming combined with MCMC-based backward-forward sweep methods. The Hamiltonian for the controlled process is defined as:

=λS,fS(X,u)+λL,fL(X,u)+λI,fI(X,u)+L(X,u),(167)

where λS,λL,λI are adjoint variables and L(X,u) is the running cost functional.

•   Initialize control variables u0(t) and state variables X0(t) over time grid t[0,T].

•   For each iteration k=1 to maximum iterations.

•   Simulate the state equations X(t) using u1(t) with Lévy noise via MCMC samples.

•   Solve the backward BSDEs for adjoint variables λ(t) using terminal conditions.

•   Hamiltonian Minimization: Update control u(t) by minimizing (X,λ,u) pointwise.

•   Check for convergence: if uu1<tol,

•   Final control u and state trajectories X.

This formulation allows us to analyze and optimize the trade-off between reducing the number of infections and the expense of applying interventions [50].

6.7 Parameter Selection and Simulation Setup

The weight parameters in the objective functional are set as 𝒞S=0.1, 𝒞L=0.5, and 𝒞I=1.0 to ensure a balanced quantitative evaluation. These values help maintain equilibrium within the disease transmission dynamics while appropriately prioritizing distinct prevention strategies. The simulation is conducted over the time interval [0,100] days, with initial conditions for each compartment specified in Section 5.1.2. The impact of the control functions uι(t), for ι=1,2,3, is analyzed in terms of minimizing the objective functional while preserving a biologically feasible and infection-stable system structure. A control intensity of t0=2.345 is selected to enhance vaccination and other prevention efforts without compromising the structural integrity of the model.

This study investigates the impact of time-dependent near-optimal control strategies within a stochastic epidemic model comprising multiple compartments. The interactions among these compartments are shaped by persistent infection dynamics, vaccination interventions, and random disturbances in transmission. To account for external uncertainties—such as environmental variability and individual behavioral changes—a Poisson random measure is incorporated into the model, effectively simulating stochastic fluctuations in disease spread.

The assessment of age-structured near-optimal strategies for mitigating CHIKV recurrence under stochastic influences is facilitated by this framework. It explicitly incorporates age-dependent interactions among susceptible, latent, and infectious individuals within each stratification category. These dynamics are influenced by behavioral patterns, vaccination policies, and external disturbances modeled via a Poisson random measure.

As illustrated in Fig. 15, targeted control measures significantly enhance the stability of the susceptible population S(t,), where denotes the age-structured cohort. In contrast, in the absence of intervention, this compartment experiences substantial declines across all age groups, highlighting the critical role of structured immunization programs and non-pharmaceutical interventions in reducing disease prevalence.

images

Figure 15: Impact of age-targeted control strategies on the CHIKV model (52). The plot demonstrates that in the presence of optimal interventions, S(t,) remains more stable across age cohorts, as opposed to the significant decline observed without control measures. This supports the analytical findings of Theorems 5 and 6, which ensure the well-posedness and boundedness of the adjoint system (64) under assumptions (166) and (167), reinforcing the efficacy and biological relevance of the proposed near-optimal control framework

Theorem 5 and Theorem 6 provide theoretical proof of the effectiveness of the suggested control strategy. The adjoint Eq. (64) is well-posed and has a unique solution (f1(t),f2(t),(t),σ(t,ϑ)) that satisfies the bound given in (68). These theorems are validated under the assumptions of (166) and (167), respectively.

These findings ensure the biological authenticity across all age groups by validating the implemented control concentrations over a short time period and confirming the stability of infectious agent dynamics. Furthermore, the model incorporates stratification across age groups, where the disease dynamics for each compartment—susceptible S(t,), latent L(t,), and infectious I(t,)—are regulated by time-dependent control variables uι(t)ι=13 that aim to mitigate disease prevalence while accounting for stochastic effects introduced via Lévy noise and Poisson random measures.

The analysis employs a Hamiltonian framework to construct an adjoint system, coupling the state dynamics with backward stochastic differential equations (BSDEs). The cost functional is defined to balance public health outcomes with control expenditures and is structured as follows:

𝒥(u1,u2,u3)=E0^[𝒞SS(t,)2+𝒞LL(t,)2+𝒞II(t,)2+ι=13Duιuι(t)2]dt.

Under the assumptions (A1)(A3), Theorem 7 guarantees the existence and uniqueness of a solution to the adjoint system E0^(f1f1~Ψ+f2f2~Ψ+tt~Ψ1Λ(t)=iπij+Yϑϑ~Ψϖ8(dς))dtCd(ωt,ω~t)Ψρ.This framework enables the evaluation of age-dependent, near-optimal strategies for controlling CHIKV outbreaks. Within each stratification category, it captures the influence of behavioral trends, immunization programs, and stochastic perturbations modeled by Poisson measures.

Tailored control strategies significantly enhance the stability of the susceptible population S(t,), where denotes the age-structure index, as demonstrated in Fig. 16. In contrast, in the absence of intervention, this compartment experiences marked declines across all age cohorts. These results emphasize the importance of coordinated vaccination and non-pharmaceutical interventions in reducing infection prevalence.

images

Figure 16: Illustration of the age-structured stochastic CHIKV model (52) dynamics incorporating control variables uι(t)ι=13 for each epidemiological compartment—susceptible S(t,), latent L(t,), and infectious I(t,)—across age groups. The model is driven by stochastic influences, with randomness introduced via Poisson random measures. A Hamiltonian framework couples the forward state dynamics with backward SDEs, leading to a cost functional that quantifies trade-offs between health outcomes and control costs. Theoretical support is provided by Theorem 7, which ensures the existence and uniqueness of solutions under assumptions (A1)(A3)

Meanwhile, this analysis incorporates time-dependent control functions and Hamiltonian analysis to derive near-optimal intervention strategies. Each compartment, including susceptible S(t,), latent L(t,), and infectious I(t,) individuals, is structured across age classes indexed by , allowing for a more granular control analysis tailored to population heterogeneity.

The control strategies uι(t) (ι=1,2,3) are designed to minimize a weighted cost functional that balances the reduction in disease burden with the cost of implementation provided in (166). Using the Hamiltonian formalism (167), the system dynamics are coupled with the adjoint processes (f1(t),f2(t),σ(t,ϑ)), and the Hamiltonian H is defined to reflect the instantaneous cost and dynamics of the system. The sufficiency condition for near-optimality is provided in Theorem 8, which ensures that under assumptions (A1)(A3), the control strategy (Υtϵ,ωtϵ) satisfies (104).

This framework facilitates a rigorous evaluation of age-specific intervention impacts in the presence of stochastic fluctuations, including behavioral variability and environmental noise, modeled through Poisson random measures. The effectiveness of these control strategies is demonstrated in Fig. 17, where the susceptible subpopulation, S(t,), exhibits enhanced stability across age groups under optimal intervention, while it declines significantly in the absence of control measures. This highlights the importance of integrating age-structured and stochastic factors into the design of epidemic control policies.

images

Figure 17: Depiction of the optimal control strategies uι(t) (ι=1,2,3), which are formulated to minimize the weighted cost functional given in (166) for CHIKV model (52). The cost balances reductions in disease burden across the susceptible S(t,), latent L(t,), and infectious I(t,) compartments with the implementation costs associated with each control. The functional incorporates weight parameters 𝒞S, 𝒞L, 𝒞I, and Duι to capture the relative priorities of epidemiological containment and resource expenditure. Utilizing the Hamiltonian framework from (167), the system is dynamically linked with adjoint variables (f1(t),f2(t),σ(t,ϑ)), and the sufficiency of the control’s near-optimality is guaranteed under Theorem 8

Moreover, near-optimal control theory, particularly when formulated through Hamiltonian structures and adjoint equations, has proven robust in epidemiological modeling where exact optimal controls are either infeasible or prohibitively costly. By leveraging the sufficiency and necessary optimality conditions (as derived in Theorem 9), the framework ensures that the proposed control strategy performs closely to an ideal optimal scenario without incurring prohibitive computational or logistical costs. This aligns with the broader stochastic control literature in mathematical epidemiology, which emphasizes trade-offs between intervention costs and epidemic mitigation [70]. Fig. 18 illustrates the decline in the infected class and the stabilization of virus/pathogen compartments under this control regime. These outcomes emphasize the importance of both the timing and intensity of interventions in managing outbreaks, especially under conditions of uncertainty.

images

Figure 18: Graphical illustration decline in the infected class and stabilization of virus/pathogen compartments under an age-structured stochastic CHIKV model (52) with near-optimal control. The model incorporates age-specific compartments and stochastic perturbations, such as Lévy noise, to capture abrupt real-world events. Intervention strategies, including age-targeted vaccination and vector control, aim to minimize a cost functional balancing epidemiological outcomes with control efforts describing the necessary criteria of Theorem 9. This approach provides a rigorous and empirically grounded methodology for designing and analyzing intervention policies in the presence of demographic diversity and random fluctuations

Together, these strands of literature validate the formulation of an age-structured stochastic CHIKV model embedded with near-optimal control. This approach provides a mathematically rigorous and empirically grounded framework for designing and analyzing intervention policies in the face of demographic diversity and random perturbations.

The figure illustrates an age-structured model for CHIKV, where the human population is divided into three epidemiological states—susceptible, latent, and infectious—across each age group . This structure reflects real-world heterogeneity in disease progression, contact patterns, and immune responses across demographic strata. As suggested by Esteva and Vargas [70] and later supported by Agusto et al. [71], such stratification is crucial for modeling age-specific interventions and evaluating their differential impacts.

Transitions between compartments are governed not only by deterministic epidemiological rates (e.g., transmission, immunization, recovery) but also by stochastic perturbations, which are modeled through a Poisson random measure superimposed with L’evy noise. This framework enables the simulation of abrupt random events, such as climate anomalies, vector density surges, or behavioral changes—phenomena increasingly observed in real epidemics, as highlighted in studies like that of Applebaum [72].

Superimposed on this structure are control arrows representing intervention strategies, denoted by the control process defined in Theorem 9, which satisfies ρ[1,2). These strategies include age-targeted vaccination, vector control, or non-pharmaceutical interventions (e.g., bed nets, awareness campaigns). The controls influence each compartment, reducing susceptibility, delaying exposure, or shortening the infectious period. The objective of these interventions is to minimize a cost functional, balancing epidemiological outcomes (infection prevalence, latency levels) against the cost of control efforts. Inspired by the frameworks of Fleming and Rishel [73] and applied to stochastic epidemic control by Buckwar and Riedler [74], the system leverages near-optimal control theory—a methodology that seeks controls that are close to optimal within a predefined error threshold. Fig. 19 demonstrates not only the interconnectedness of age-specific compartments but also the multi-objective nature of epidemic control under uncertainty. The near-optimal control conditions are governed by a Hamiltonian framework, and necessity conditions (as detailed in theorems like Theorem 9 in this work) are imposed to ensure performance guarantees despite the stochastic noise. In summary, the figure encapsulates a mathematically rigorous and biologically informed framework for designing and analyzing control policies for CHIKV epidemics. It is firmly grounded in the current literature on stochastic differential equations, optimal control theory, and age-structured modeling. Additionally, the control parameters and statistical variations used in the simulation inputs are summarized in Table 6. Model calibration and validation show strong agreement between theoretical projections and observed epidemic behavior, further supporting the framework’s reliability. The close match between synthetic and observed trends confirms that the model accurately captures the nonlinear and stochastic dynamics of CHIKV transmission.

images

Figure 19: Highlights for the interconnectedness of age-specific compartments and the multi-objective nature of CHIKV epidemic model (52) control under uncertainty. Governed by a Hamiltonian framework, the near-optimal control conditions ensure robustness against stochastic perturbations. The model integrates age structure, stochastic dynamics, and optimal control theory, providing a reliable and biologically informed basis for policy design supported by the argument of Theorem 9, such as 1<ρ<2. Calibration results, summarized in Table 6, demonstrate strong alignment between simulated outcomes and observed epidemic trends

images

7  Conclusion

CHIKV, an arthropod-transmitted alphavirus of the Togaviridae family, remains one of the most significant arthropod-borne viral infections in humans. This study presents a non-autonomous SDE model that incorporates age-structured dynamics and time-dependent prevalence variations to examine the impact of screening and therapeutic strategies on CHIKV spread. By modeling stochastic disruptions through Poisson random measures, the methodology captures sudden and unexpected changes influencing CHIKV transmission. For the Lévy-based model, we derive global positive solutions, ensuring the system’s biological feasibility.

The main contributions have been presented as:

•   Developed an age-structured stochastic model that integrates demographic, immunization, and therapeutic interventions to more accurately estimate the basic reproduction number (R0L) under stochastic influences.

•   Applied MCMC calibration to fit model predictions to monthly CHIKV incidence data (Florida, USA, 2005–2017), estimating undetermined parameters and initial conditions reliably.

•   Provided sensitivity assessments across age groups using 95% confidence intervals, prediction intervals, and training-testing validation, offering practical insights into which populations are most at risk.

•   Derived near-optimal control strategies using linear constraints and Ekeland’s variational principle, enabling precise evaluation of interventions.

•   The model can guide public health interventions by identifying age groups with higher CHIKV incidence and evaluating the impact of vaccination and treatment strategies.

•   Computed threshold parameter R0L indicates disease persistence patterns, informing epidemic preparedness and resource allocation.

•   Predictions show that individuals over 66 years old have the highest incidence, while those under 16 are least affected, allowing targeted interventions.

Furthermore, future directions include extending the model to multi-variable systems with co-infections and environmental factors, using advanced methods such as deep learning or Kalman filters to improve predictions and validation across regions. The study is limited by assumptions of homogeneous mixing, ignored spatial or vector heterogeneity, and higher computational costs. Despite these, the framework offers valuable insights for CHIKV control and epidemic modeling.

Acknowledgement: The authors would like to thank the Ongoing Research Funding program (ORF-2025-1404), King Saud University, Riyadh, Saudi Arabia.

Funding Statement: Ongoing Research Funding program (ORF-2025-1404), King Saud University, Riyadh, Saudi Arabia.

Author Contributions: The authors confirm contribution to the paper as follows: study conception and design: Maysaa Al-Qurashi, Ayesha Siddiqa; data collection: Shazia Karim, Yu-Ming Chu; analysis, project administration and interpretation of results: Saima Rashid; draft manuscript preparation: Ayesha Siddiqa, Yu-Ming Chu. All authors reviewed the results and approved the final version of the manuscript.

Availability of Data and Materials: Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Ethics Approval: Not applicable.

Conflicts of Interest: The authors declare no conflicts of interest to report regarding the present study.

References

1. World Health Organization. Global chikungunya report 2021. Comput Electr Eng. 2021;92:107129. [Google Scholar]

2. Fritsch H, Giovanetti M, Xavier J, Adelino TER, Fonseca V, de Jesus JG, et al. Retrospective genomic surveillance of chikungunya transmission in Minas Gerais State, Southeast Brazil. Microbiol Spectr. 2022;10(5):e0128522. doi:10.1128/spectrum.01285-22. [Google Scholar] [PubMed] [CrossRef]

3. Cerqueira-Silva T, Pescarini JM, Cardim LL, Leyrat C, Whitaker H, Antunes de Brito CA, et al. Risk of death following chikungunya virus disease in the 100 million Brazilian cohort, 2015–2018: a matched cohort study and self-controlled case series. Lancet Infect Dis. 2024;24:504–13. doi:10.1016/S1473-3099(23)00567-8. [Google Scholar] [CrossRef]

4. Khongwichit S, Chansaenroj J, Chirathaworn C, Poovorawan Y. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. J Biomed Sci. 2021;28(1):84. doi:10.1186/s12929-021-00778-8. [Google Scholar] [PubMed] [CrossRef]

5. Traverse EM, Millsapps EM, Underwood EC, Hopkins HK, Young M, Barr KL. Chikungunya immunopathology as it presents in different organ systems. Viruses. 2022;14(8):1786. doi:10.3390/v14081786. [Google Scholar] [PubMed] [CrossRef]

6. Costa D, Gouveia P, Silva GEB, Neves P, Vajgel G, Cavalcante M, et al. The relationship between chikungunya virus and the kidneys: a scoping review. Rev Med Virol. 2023;33(1):e2357. doi:10.1002/rmv.2357. [Google Scholar] [PubMed] [CrossRef]

7. Brandler S, Ruffié C, Combredet C, Brault J-B, Najburg V, Prevost M-C, et al. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine. 2013;31(36):3718–25. doi:10.1016/j.vaccine.2013.05.086. [Google Scholar] [PubMed] [CrossRef]

8. Chattopadhyay S, Roy A, Banerjee A, Goswami R, Basu A, Jana AM. Development and characterization of monoclonal antibody against non-structural protein-2 of chikungunya virus and its application. J Virol Methods. 2014;199:86–94. doi:10.1016/j.jviromet.2014.01.008. [Google Scholar] [PubMed] [CrossRef]

9. Mavale M, Parashar D, Sudeep A, Yadav PD, Gokhale MD, Mourya DT. Venereal transmission of chikungunya virus by Aedes aegypti mosquitoes (Diptera: culicidae). Am J Trop Med Hyg. 2010;83(6):1242–4. doi:10.4269/ajtmh.2010.09-0577. [Google Scholar] [PubMed] [CrossRef]

10. Goh LY, Tan HC, Lim XF, Ho BC, Sam IC, Chan YF, et al. Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model. Clin Immunol. 2013;149(3):487–97. doi:10.1016/j.clim.2013.10.004. [Google Scholar] [PubMed] [CrossRef]

11. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007;3(6):e89. doi:10.1371/journal.ppat.0030089. [Google Scholar] [PubMed] [CrossRef]

12. Gérardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 2008;5:e60. [Google Scholar]

13. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370(9602):1840–6. doi:10.1016/s0140-6736(07)61779-6. [Google Scholar] [PubMed] [CrossRef]

14. Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis. 2006;6(8):463–4. doi:10.1016/s1473-3099(06)70531-x. [Google Scholar] [PubMed] [CrossRef]

15. Servant MJ, Tenoever B, Lin R. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res. 2002;22(1):49–58. doi:10.1089/107999002753452656. [Google Scholar] [PubMed] [CrossRef]

16. Brito CA, Teixeira MG. Increased number of deaths during a chikungunya epidemic in Pernambuco, Brazil. Mem Inst Oswaldo Cruz. 2017;112(9):650–1. doi:10.1590/0074-02760170124. [Google Scholar] [PubMed] [CrossRef]

17. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol. 2006;177(5):3260–5. doi:10.4049/jimmunol.177.5.3260. [Google Scholar] [PubMed] [CrossRef]

18. Rashid S, Jarad F. Novel investigation of stochastic fractional differential equations measles model via the white noise and global derivative operator depending on mittag-leffler kernel. Comput Model Eng Sci. 2024;139(3):2289–327. doi:10.32604/cmes.2023.028773. [Google Scholar] [CrossRef]

19. Arif MS, Abodayeh K, Nawaz Y. Construction of a computational scheme for the fuzzy HIV/AIDS epidemic model with a nonlinear saturated incidence rate. Comput Model Eng Sci. 2024;138(2):1405–25. doi:10.32604/cmes.2023.028946. [Google Scholar] [CrossRef]

20. Jajarmi A, Baleanu D, Rezapour S, Mohammadi H. A new fractional analysis on the interaction of HIV with CD4+ T-cells. Chaos Soliton Fract. 2018;115(4):1–10. doi:10.1016/j.chaos.2018.06.009. [Google Scholar] [CrossRef]

21. Bellan SE. The importance of age dependent mortality and the extrinsic incubation period in models of mosquito-borne disease transmission and control. PLoS One. 2010;5(4):e10165. [Google Scholar] [PubMed]

22. Olayiwola MO, Oluwafemi EA. Modeling tuberculosis dynamics with awareness and vaccination using laplace-adomian and fractional calculus. Iran J Sci. 2025;1(1):78. doi:10.1007/s40995-025-01830-0. [Google Scholar] [CrossRef]

23. Olayiwola MO, Tijani KR, Ogunniran MO, Yunus AO, Oluwafemi EA, Abanikanda MO, et al. Modeling the booster vaccine effect on new COVID-19 variant management employs the Atangana-Baleanu-Caputo fractional derivative operator together with the Laplace-Adomian decomposition method. Vacunas. 2025;26(3):500458. doi:10.1016/j.vacun.2025.500458. [Google Scholar] [CrossRef]

24. Mohamed Ali H, Mahdy AM, El-Mesady A. Investigation of stability criteria and optimal control measures for a fractional-order model of human papillomavirus infection and cervical cancer. Int J Biomathematics. 2025;18:1–15. doi:10.1142/s1793524525500639. [Google Scholar] [CrossRef]

25. El-Mesady A, Al-Shami TM, Ali HM. Optimal control efforts to reduce the transmission of HPV in a fractional-order mathematical model. Bound Value Probl. 2025;42(1):1–18. doi:10.1186/s13661-024-01991-8. [Google Scholar] [CrossRef]

26. Buonomo B. Analysis of a malaria model with mosquito host choice and bed-net control. Int J Biomathematics. 2015;8(1550):077. doi:10.1142/s1793524515500771. [Google Scholar] [CrossRef]

27. Chitnis N, Smith T, Steketee R. A mathematical model for the dynamics of malaria in mosquitoes feeding on a heterogeneous host population. J Biol Dyn. 2008;2(3):259–85. doi:10.1080/17513750701769857. [Google Scholar] [PubMed] [CrossRef]

28. Zhang L, Zhou Q, Yang J. Necessary condition for optimal control of doubly stochastic systems. Math Control Relat Fields. 2020;10(2):379–403. doi:10.3934/mcrf.2020002. [Google Scholar] [CrossRef]

29. Huang J, Li X, Wang G. Near-optimal control problems for linear forward-backward stochastic systems. Automatica. 2010;46(2):397–404. doi:10.1016/j.automatica.2009.11.016. [Google Scholar] [CrossRef]

30. Yong J, Zhou X. Stochastic control: hamilton systems and HJB equations. New York, NY, USA: Springer; 1999. [Google Scholar]

31. Ji C. Dynamics of a multigroup SIR epidemic model with stochastic perturbation. Automatica. 2012;48(8):1859–67. doi:10.1016/j.automatica.2011.09.044. [Google Scholar] [CrossRef]

32. Yang Q. The ergodicity and extinction of stochastically perturbed SIR and SEIR epidemic models with saturated incidence. J Math Anal Appl. 2012;386(2):722–38. doi:10.1016/j.jmaa.2011.11.072. [Google Scholar] [CrossRef]

33. Dereich S, Heidenreich F, Scheutzow M. A multilevel Monte Carlo algorithm for Lévy-driven stochastic differential equations. Stochastic Process Appl. 2011;121(12):2597–17. doi:10.1016/j.spa.2011.03.015. [Google Scholar] [CrossRef]

34. Rubenthaler S. Numerical simulation of the solution of a stochastic differential equation driven by a Lévy process. Stochastic Process Appl. 2003;103(2):313–32. doi:10.1016/s0304-4149(02)00191-6. [Google Scholar] [CrossRef]

35. Zhou Y, Yuan S, Zhao D. Threshold behavior of a stochastic SIS model with Lévy jumps. Appl Math Comput. 2016;275:255–67. [Google Scholar]

36. Liu M, Bai C. Optimal harvesting of a stochastic mutualism model with Lévy jumps. Appl Math Comput. 2016;276(247):301–9. doi:10.1016/j.amc.2015.11.089. [Google Scholar] [CrossRef]

37. Shu H, Jin HY, Wang XS, Wu J. Viral infection dynamics with immune chemokines and CTL mobility modulated by the infected cell density. J Math Biol. 2024;88(4):43. [Google Scholar] [PubMed]

38. Dubey P, Dubey US, Dubey B. Modeling the dynamics of viral-host interaction during treatment of productively infected cells and free virus involving total immune response. Nonlinear Anal Model Control. 2021;26(4):678–701. doi:10.15388/namc.2021.26.21434. [Google Scholar] [CrossRef]

39. Handel A, Antia R. A simple mathematical model helps to explain the immunodominance of CD8 T cells in influenza A virus infections. J Virol. 2008;82(16):7768–72. doi:10.1128/jvi.00653-08. [Google Scholar] [PubMed] [CrossRef]

40. Cui T, Liu P, Din A, Khan A. Impact of Lévy noise on a stochastic Norovirus epidemic model with information intervention. Math Methods Appl Sci. 2023;46(6):4715–30. doi:10.1002/mma.9655. [Google Scholar] [CrossRef]

41. Gikhman II, Skorokhod AV. Stochastic differential equations. Berlin/Heidelberg, Germany: Springer; 2007. [Google Scholar]

42. El Fatini M, Sekkak I. Lévy noise impact on a stochastic delayed epidemic model with Crowley-Martin incidence and crowding effect. Physica A. 2020;541(2):123315. doi:10.1016/j.physa.2019.123315. [Google Scholar] [CrossRef]

43. Din A, Li Y. Lévy noise impact on a stochastic hepatitis B epidemic model under real statistical data and its fractal-fractional Atangana–Baleanu order model. Phys Scr. 2021;96(12):124008. doi:10.1088/1402-4896/ac1c1a. [Google Scholar] [CrossRef]

44. Zhang XB, Wang XD, Huo HF. Extinction and stationary distribution of a stochastic SIRS epidemic model with standard incidence rate and partial immunity. Physica A. 2019;531(3):121548. doi:10.1016/j.physa.2019.121548. [Google Scholar] [CrossRef]

45. Song Y, Liu P, Din A. A novel stochastic model for human Norovirus dynamics: vaccination impact with Lévy noise. Fractal Fract. 2024;8(6):349. [Google Scholar]

46. Hafayed M, Abbas S. On near-optimal mean-field stochastic singular controls: necessary and sufficient premises for near-optimality. J Optim Theory Appl. 2014;160(3):778–808. doi:10.1007/s10957-013-0361-1. [Google Scholar] [CrossRef]

47. Liu Z, Guo S, Tan R, Liu M. Modeling and analysis of a non-autonomous single-species model with impulsive and random perturbations. Appl Math Model. 2016;40(9–10):5510–31. doi:10.1016/j.apm.2016.01.008. [Google Scholar] [CrossRef]

48. Kuang D, Li J, Gao D, Luo D. Stochastic near-optimal control for a system with Markovian switching and Lévy noise. Chaos Soliton Fract. 2024;178:114360. doi:10.1016/j.chaos.2023.114360. [Google Scholar] [CrossRef]

49. Donnelly C. Sufficient stochastic maximum principle in a regime-switching diffusion model. Appl Math Optim. 2011;64(2):155–69. doi:10.1007/s00245-010-9130-9. [Google Scholar] [CrossRef]

50. Peng S. A general stochastic maximum principle for optimal control problems. SIAM J Control Optim. 1990;28(4):966–79. doi:10.1137/0328054. [Google Scholar] [CrossRef]

51. Li M, Wu Z. Necessary and sufficient assertions of near-optimality in a regime-switching diffusion model. Optim Control Appl Methods. 2020;41(3):793–807. doi:10.1002/oca.2571. [Google Scholar] [CrossRef]

52. Mao X. Stochastic differential equations and applications. Amsterdam, The Netherland: Elsevier; 2007. [Google Scholar]

53. Ekeland I. On the variational principle. J Math Anal Appl. 1974;47(2):324–53. [Google Scholar]

54. Zhu Y, Wang L, Qiu Z. Dynamics of a stochastic cholera epidemic model with Lévy process. Physica A. 2022;595(1):127069. doi:10.1016/j.physa.2022.127069. [Google Scholar] [CrossRef]

55. Ain QT, Din A, Qiang X, Kou Z. Dynamics for a nonlinear stochastic cholera epidemic model under Lévy noise. Fractal Fract. 2024;8(5):293. doi:10.3390/fractalfract8050293. [Google Scholar] [CrossRef]

56. Mao X, Wei F, Wiriyakraikul T. Positivity preserving truncated Euler–Maruyama method for stochastic Lotka-Volterra competition model. J Comput Appl Math. 2021;394(3):113566. doi:10.1016/j.cam.2021.113566. [Google Scholar] [CrossRef]

57. Data-Center of USA Public Health Science. Data director [Internet]. 2023 [cited 2025 Jul 16]. Available from: https://www.phsciencedata.usa/Share/en/index.jsp. [Google Scholar]

58. Florida Department of Economic and Demographic Research, U.S. Census Bureau. Population data for florida, 2005–2019 [Internet]. 2023 [cited 2025 Jul 16]. Available from: http://edr.state.fl.us/Content/population-demographics/data/index.cfm. [Google Scholar]

59. Byers NM, Fleshman AC, Perera R, Molins CR. Metabolomic insights into human arboviral infections: dengue, Chikungunya, and Zika viruses. Viruses. 2019;11(3):225. doi:10.3390/v11030225. [Google Scholar] [PubMed] [CrossRef]

60. de Lima STS, de Souza WM, Cavalcante JW, Candido DDS, Fumagalli MJ, Carrera J-P, et al. Fatal outcome of Chikungunya virus infection in Brazil. Clin Infect Dis. 2021;73:2436–43. [Google Scholar]

61. Reisinger EC, Tschismarov R, Beubler E, Wiedermann U, Firbas C, Loebermann M, et al. Immunogenicity, safety, and tolerability of the measles-vectored Chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Lancet. 2018;392(10165):2718–27. doi:10.1016/s0140-6736(18)32488-7. [Google Scholar] [PubMed] [CrossRef]

62. Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Roux K, et al. Correction: chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137. doi:10.1371/journal.pntd.0002137. [Google Scholar] [PubMed] [CrossRef]

63. Cazelles B, Chavez M, De Magny GC, Guegan J, Hales S. Time-dependent spectral analysis of epidemiological time-series with wavelets. J R Soc Interface. 2007;4(15):625–36. doi:10.1098/rsif.2007.0212. [Google Scholar] [PubMed] [CrossRef]

64. Centers for Disease Control and Prevention (CDC). Population census and population estimates [Internet]. 2023 [cited 2025 Jul 16]. Available from: https://www.cdc.gov/nchs/hus/sources-definitions/census-population.htm. [Google Scholar]

65. Haario H, Laine M, Mira A, Saksman E. DRAM: efficient adaptive MCMC. Stat Comput. 2006;16(4):339–54. doi:10.1007/s11222-006-9438-0. [Google Scholar] [CrossRef]

66. Cressie NAC. Statistics for spatial data. Revised ed. New York, NY, USA: Wiley; 1993. [Google Scholar]

67. Wikipedia. One in ten rule [Internet]. 2022 [cited 2025 Mar 26]. Available from: https://en.wikipedia.org/wiki/One_in_ten_rule. [Google Scholar]

68. McKay MD, Beckman RJ, Conover WJ. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics. 1979;21(2):239–45. doi:10.1080/00401706.1979.10489755. [Google Scholar] [CrossRef]

69. Huang M, Caines PE. Pontryagin’s maximum principle for mean field stochastic control problems. SIAM J Control Optim. 2009;48(8):5145–75. [Google Scholar]

70. Esteva L, Vargas C. Analysis of a model for the transmission dynamics of the dengue virus in a human population. Math Biosci. 1998;149(1):41–61. doi:10.1016/S0025-5564(98)00006-6. [Google Scholar] [CrossRef]

71. Agusto FB, Mbohwa C, Lokossou T. Modeling and analysis of age-structured population for the control of vector-borne diseases. Math Biosci Eng. 2016;13(2):263–81. doi:10.3934/mbe.2016.13.263. [Google Scholar] [CrossRef]

72. Applebaum D. Lévy processes and stochastic calculus. 2nd ed. Cambridge, UK: Cambridge University Press; 2009. [Google Scholar]

73. Fleming WH, Rishel RW. Deterministic and stochastic optimal control. 1st ed. New York, NY, USA: Springer-Verlag; 1975. [Google Scholar]

74. Buckwar E, Riedler M. Adaptive control for stochastic epidemic models. Math Biosci Eng. 2011;8(4):935–50. doi:10.3934/mbe.2011.8.935. [Google Scholar] [CrossRef]


Cite This Article

APA Style
Al-Qurashi, M., Siddiqa, A., Karim, S., Chu, Y., Rashid, S. (2025). Demographic Heterogeneities in a Stochastic Chikungunya Virus Model with Poisson Random Measures and Near-Optimal Control under Markovian Regime Switching. Computer Modeling in Engineering & Sciences, 145(2), 2057–2129. https://doi.org/10.32604/cmes.2025.071629
Vancouver Style
Al-Qurashi M, Siddiqa A, Karim S, Chu Y, Rashid S. Demographic Heterogeneities in a Stochastic Chikungunya Virus Model with Poisson Random Measures and Near-Optimal Control under Markovian Regime Switching. Comput Model Eng Sci. 2025;145(2):2057–2129. https://doi.org/10.32604/cmes.2025.071629
IEEE Style
M. Al-Qurashi, A. Siddiqa, S. Karim, Y. Chu, and S. Rashid, “Demographic Heterogeneities in a Stochastic Chikungunya Virus Model with Poisson Random Measures and Near-Optimal Control under Markovian Regime Switching,” Comput. Model. Eng. Sci., vol. 145, no. 2, pp. 2057–2129, 2025. https://doi.org/10.32604/cmes.2025.071629


cc Copyright © 2025 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 216

    View

  • 85

    Download

  • 0

    Like

Share Link